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INTRODUCTION 
Herpesviruses have been isolated from almost all species and give 
rise to a variety of disease syndromes. The bovine herpesviruses 
especially are associated with a diversity of clinical disease un-
paralleled by any other group of viruses affecting cattle. 
Infectious bovine rhinotracheitis and bovine herpes mammillitis 
are two examples of relatively new and important diseases recognized 
since the 1950s. Under more traditional systems of livestock production, 
as in many Third World countries, the infections caused by bovine 
herpesviruses have rarely been of great economic significance. Only 
with the development of more intensive systems of animal production 
have problems emerged. In many developing countries of Africa, South 
America and Asia, the isolation of different bovine herpesviruses has 
been recorded (Gibbs and Rweyemamu, 1977a,b). This circumstance may 
hinder the attempts to develop intensive, more productive methods of 
cattle raising. 
Though the economic importance of the diseases caused by bovine 
herpesviruses is a strong reason that warrants the continuing attention 
of veterinarians and virologists, it is not the only one. Actually, 
the diversity of disease associated with the bovine herpesviruses and 
human herpesviruses follows a similar pattern. In this respect, latent 
or chronic infections in cattle as well as the possible role of bovine 
herpesviruses in cattle oncogenic processes have become an appealing 
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subject for comparative virologists. 
From all of this, it can be concluded that a more complete under-
standing of the bovine herpesvirus group is required. 
During the last two decades the list of herpesviruses originating 
from cattle has been expanded considerably. Specifically, a large 
number of isolates recovered from diverse clinical syndromes as well 
as from clinically normal cattle have been placed in the bovine 
herpesvirus-4 (BHV-4) group (also referred as Bovid Herpesvirus-4) 
(WHO/FAD, 1976; Straub, 1978; Mohanty, 1980). The members of this group 
are geographically widespread (Africa, Near East, Europe and U.S.A.). 
The characteristic of poor inducer of neutralizing antibodies is common 
to all of these isolates. This last feature, in addition to a limited 
sensitivity of the standard seroneutralization assays in use, determined 
that not all of them have been compared serologically. In most cases, 
there is no evidence to implicate them as the primary etiological agents 
of the clinical syndromes from which they were isolated and experimental 
inoculation with these agents in all but a few instances has failed to 
elicit any clinical disease. 
The purpose of this work was to investigate the response of cattle 
and rabbits experimentally infected with one strain of BHV-4 (75-3374) 
isolated by Reed et al. (1977) from a case of mammary pustular dermatitis. 
Although no evidence of the pathogenicity of this strain could be found, 
it has been possible to characterize an association of the virus with 
lymphoid organs and peripheral blood leukocytes in'vivo and demonstrate 
persistence of the virus for extended periods of time, 
3 
Explanation of Thesis Format 
This thesis consists of an introduction, a literature review, 
two separate manuscripts, a general conclusion, references and 
acknowledgements, The master's candidate, Fernando Abel Osorio, 
is the senior author and principal investigator for each of the 
manuscripts. 
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LITERATURE REVIEW 
Family Herpesviridae 
The International Committee on Taxonomy of Viruses (ICTV) (1979) 
has defined the DNA-containing viruses with envelopes or complex coats 
as belonging to one of 3 large families: Herpesviridae, Iridoviridae 
and Poxviridae. 
The main characteristics of the family Herpesviridae include: 
an enveloped icosahedral capsid with 162 capsomers; an average diameter 
of 100 nm for the naked virus and up to 200 nm for enveloped virus; 
assembly of the capsid in the cell nucleus with envelopment of the 
nucleocapsid at the nuclear membrane; extreme sensitivity to ether; a 
genome composed of one molecule of linear double stranded 
nucleic acid of molecular weight ranging from 80 to 150 x 
and a ratio G + C between 32 and 82% (ICTV, 1979). 
deoxyribo-
6 10 daltons 
Three subfamilies have been delineated for members of Herpesviridae, 
leaving some herpesviruses unclassified and no genera formally named 
(ICTV, 1979). The three subfamilies have been defined mainly on the 
basis of the replicative characteristics of the virus members and their 
persistence features and consist of 1) Alphaherpesvirinae, comprising 
the herpes simplex virus group, of relatively short <<24 h) replicative 
cycle and latent virus infection frequently demonstrated in ganglia and 
other nervous tissue, 2) Betaherpesvirinae, the cytomegalovirus group, 
of slow reproductive cycle ()24 h), with enlargement of the infected 
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cell in vivo and often in vitro (cytomegalia) and persistence of the 
virus in epithelia (salivary glands) and other (e.g. lymphoid) tissues, 
3) Gammaherpesvirinae, comprising the lymphoproliferative group, 
characterized by restricted replication in lymphoblastoid cells and 
lytic infections in some types of epithelioid cells and fibroblastic 
cells. The latent virus is frequently demonstrated in lympho-id tissue. 
Prototype viruses have been named for each subfamily and other members 
have been assigned where information was.sufficient to make this 
possible. These reference prototypes have been taken from among the 
more studied and well-characterized human herpesviruses. For Alpha-
herpesvirinae, the prototype is human (alpha). herpesvirus-1 (herpes 
simplex virus). For Betaherpesvirinae, the prototype is human (beta) 
herpesvirus-5 (human cytomegalovirus) and for Gammaherpesvirinae human 
(gamma) herpesvirus-4 (Epstein-Barr virus) is the prototype. 
Herpesviruses of Cattle 
Under the provisional classification described above, other 
members of each subfamily include not only other herpesviruses of man 
but also herpesviruses of other hosts, each of which is given a numerical 
designation among the herpesviruses named according to their natural 
host species. This is at variance with the previous proposals of the 
Herpesvirus Study Group of the ICTV (Roizman, 1973) which had suggested 
that all herpesviruses should be named according to the taxonomic unit--
the family-- of the hosts. This last system was not ratified by the 
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ICTV (Fenner, 1976) and was considered inconvenient (Gibbs and 
Rweyemamu, 1977a) in that most of the mammalian-families are extremely 
diverse (i.e. family Bovidae includes 128 species). 
The co-existence of both classification criteria during a certain 
period of time created some degree of confusion between the different 
authors who attempted to bring order to the great number of herpes-
viruses isolated from cattle. McKercher (1973), in the first systematic 
review published on herpesviruses of veterinary importance, used the 
species name to denominate the two well-known herpesviruses of cattle: 
bovine herpesvirus-1 (infectious bovine r.hinotracheitis virus) and 
bovine herpesvirus-2 (bovine herpes mammillitis/Allerton virusj. 
The Herpesvirus Study Group of the ICTV (Roizman, 1973) included 
the ~alignant catarrhal fever virus and the virus of ovine pulmonary 
adenomatosis (Verwoed et al., 19i9) within the Bovid herpesvirus group 
and called them Bovid herpesvirus 1, 2, 3 and 4 respectively. 
Smith (1977), following this family-based pattern, proposed the 
designation Bovid herpesvirus-5 for a group of different isolates 
serologically related to the European isolate Movar 33/63 (Movar group) 
which had demonstrated no relationship to the previously known bovine 
herpesviruses. At the same time, and despite this proposition, some 
other authors referred to this Movar group as bovine herpesvirus III 
(Gibbs and Rweyemamu, 1977b; Eugster, 1978). The rationale for this 
conflicting classification was that these authors did not include in 
their listing the virus of malignant catarrhal fever as a herpesvirus 
7 
of cattle which was considered to be mainly a virus from wildebeest and 
other Alcelaphinae. 
The Consultation on the WHO/FAO Programme on Comparative Virology, 
held in 1976 (WHO/FAO, 1976), although deciding nothing conclusive 
about herpesvirus naming and classification, provided a tentative 
working list of the herpesviruses of cattle. The FAO list recognized 
4 antigenically different types of bovine herpesviruses, (Table 1) 
and indicated a prototype strain in each. The virus of pulmonary 
adenomatosis of sheep was not included. This tentative classification 
became generally accepted and was used by the more recent reviews in 
the field (Mohanty, 1978, 1980; Straub, 1978). 
The antigenic differences among these 4 serotypes of bovine 
herpesviruses correlate with distinctive patterns of pathogenesis, 
immunogenicity and persistence that are well-characterized for BHV-1, 
BHV-2 and BHV-3. An attempt will be made to summarize the differential 
characteristics of each of these groups and a special emphasis will 
be given to the available information on the less well-defined and newly 
recognized BHV-4 group. 
Bovine herpesvirus-1 (BHV-1) 
BHV-1 was the first viral agent shown to cause respiratory infection 
in cattle. The virus is associated with rhinotracheitis, conjunctivitis, 
vulvovaginitis, balanoposthitis, meningoencephalitis, and neonatal 
infection .(Kahrs, 1977). From these respiratory and reproductive 
Table 1. Herpesviruses of cattle 
* Type 
BOVINE ~ERPESVIRUS - 1 
BOVINE HERPESVIRUS - 2 
BOVINE HERPESVIRUS - 3 
BOVINE HERPESVIRUS - 4 
UNCLASSIFIED 
* 
Vernacular name 
Infectious bovine 
rhinotracheitis virus (IBRV) 
Bovine herpes mammillitis/ 
Allerton virus (BHMV) 
Malignant catarrhal fever 
virus (MCFV) 
Movar/Orphan herpesviruses 
"Epivag" associated 
slow CPE viruses 
Syncytial herpesvirus from 
lymphosarcomatous cattle 
Reference strain 
COLORADO I (York et al., 1957) 
USA 
BOVINE MAMMILLITIS 
(Martin et al., 1964) U.K. 
WC II 
(Plowright, 1968) Africa 
MOVAR 33/63 
(Bartha et al., 1966) Hungary 
,,, 
(Mare and Van Resburg, 1961; 
Theodoridis, 1978) S. Africa 
(Van der Maaten and Boothe, 
1972) USA 
The four types with numerical nomenclature correspond to the groups proposed by the 
WHO/FAQ Consultation on Comparative Virology (WHO/FAO, 1976) and they are referred also as 
Bovid herpesvirus 1, 2, 3 and 4. 
00 
9 
symptoms were derived the vernacular names of the virus: infectious 
bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) 
virus. However, isolates from the genital tract were shown to produce 
respiratory illness and vice versa (McKercher, 1973) demonstrating the 
etiological uniqueness of the virus for both syndromes. 
The virus has a fast cytopathic effect (CPE) in infected tissue 
culture cells, being complete in less than 24 hrs. The infected cells 
become rounded, frequently ballooned and some not infrequent small 
refractile syncytia are present. As the CPE progresses, strands of 
cytoplasm are seen linking affected cells (Gibbs and Rweyemamu, 1977a), 
The humeral immune response to IBR virus is characterized by high 
titered serum-neutralizing antibodies, as well as antibodies with 
cytolytic and antibody-dependent cell-mediated cytotoxicity (ADCC) 
inducer capabilities (Rouse et al., 1976). The cell-mediated immunity 
has b:en demonstrated to play a principal role in the prevention of 
virus spread and recovery from disease (Davies and Carmichael, 1973; 
Rouse and Babiuk, 1974). 
The virus has the ability to persist after acute infection in 
inoculated animals. As other members of the alphaherpesvirus group, 
BHV-1 persists in sensory and autonomic nerve ganglia (Narita et al., 
1978; Homan and Easterday, 1980a). The persistence in trigeminal 
ganglia and recurrence also has been demonstrated in rabbits (Rock, 
D. L., 1981. Persistent infection with bovine herpesvirus-1: a rabbit 
model. Ph.D. dissertation, Iowa State University, Ames, IA, USA). 
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Bovine herpesvirus-2 (BHV-2) 
BHV-2 causes severe skin lesions on the udder and on the teats 
of cows and heifers shortly after calving. The virus has been isolated 
in eastern and southern Africa, Europe, the United States, and 
Australia (Smith, 1977). The disease occurs in 2 distinct forms: 
1) generalized nodular lesions on large areas of the skin over various 
parts of the body, 2) localized necrotic ulcerations on the skin of 
the teats, udder, escutcheon and perineum. 
The first isolation of the virus causing generalized skin disease 
(Allerton virus) was by Alexander et al. (1957) from cases of lumpy 
skin disease in southern Africa. It emerged from this work that the 
disease, once considered as one etiological entity could be caused by 
a pox virus (prototype Neethling) or by a herpesvirus (BHV-2: Allerton 
virus). The disease caused by Allerton virus was demonstrated to be 
benign and in order to distinguish it from the more severe poxvirus 
infection it has generally been called pseudo-lumpy skin disease (PLSD). 
The nodules in the skin due to BHV-2 appear most frequently on the face, 
neck, back, and perineum. The nodules are firm, round, raised areas 
presenting a flat surface with a slightly depressed center (Gibbs and 
(Rweyemamu, 1977b). 
The mammary form of BHV-2 was known for a long time, but the 
significance of BHV-2 as a specific cause of mammillitis was not realized 
until the work of Martin et al. (1964) in England, who reported the 
isolation of BHV-2 from teats. Bovine herpesvirus-2 has also been 
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isolated from oral and facial lesions of cattle and buffalo calves. 
In all the cases where the dam has been examined, a concurrent 
mammillitis has been confirmed (Gibbs and Rweyernamu, 1977b). 
The cytopathic effect of BHV-2 in tissue cultures is characterized 
by the formation of large syncytial masses. The syncytia may be either 
globose or stellate with or without transyncytial vacuolation (Gibbs and 
Rweyemamu, 1977b). The CPE is fast, ((24 h) and can be evident as 
early as 12 hours after inoculation. Often the syncytia may involve 
practically the whole monolayer before the sheet disintegrates and 
becomes detached from the glass in balls (Alexander et al., 1957; 
Gibbs and Rweyemamu, 1977b). 
In natural infections, the development of antibody is rapid and 
can be assayed by seroneutralization tests. Some authors found per-
sistence of neutralizing antibodies for at least 8 months (Gibbs and 
Rweyemamu, 1977b); others reported antibody to decline to barely 
detectable levels at four months after inoculation (Kalunda and 
Plowright, 1972). 
There is good evidence demonstrating persistent infection with 
BHV-2. Martin and Scott (1979) demonstrated recrudescence of the 
in calves following corticosteroid administration, 10 weeks or later 
after initial infection. Although it is not possible to indicate in 
which tissues or organs BHV-2 remains latent, there is evidence that 
the lesions recurs at the same site as the initial lesion. BHV-2 
has been included in the alphaherpesvirus group together with BHV-1 
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(ICTV, 1979). 
Bovine herpesvirus-3 (BHV-3) 
BHV-3 causes a natural clinical disease called malignant catarrhal 
fever (MCF) only in cattle and domestic buffaloes. Nevertheless, the 
primary hosts for this virus are members of the family Alcelaphinae 
(wildebeest, hartebeest and topi). These animals are asymptomatic 
carriers for MCFV. For this reason some authors proposed that MCFV 
not be considered a bovine herpesvirus (Gibbs and Rweyemamu, 1977a), 
but as an Alcephalinae herpesvirus. 
The disease is worldwide in distribution, but its incidence is 
generally sporadic and low. It often terminates in fatal encephalitis, 
usually 5 to 12 days after onset of pyrexia (Mohanty, 1978). It is 
believed that the causative agent is acquired by cattle from inapparently 
infected sheep or from wildebeest (in areas like Africa, where a cattle-
wildebeest contact is likely) (Plowright, 1968). 
The virus produces multinucleated, often vacuolated syncytia. 
The infectivity titer is extremely low, and the virus is highly cell-
associated. In the beginning, MCFV induces very small non-progressive 
CPE and is not transmissible by cell-free fluids (Plowright, 1968). 
The virus produces a fatal lymphoid proliferation and angitis 
after experimental infection in cattle and rabbits (Plowright, 1968). 
Virus may be recovered from leucocytes 3 to 15 days before the terminal 
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pyrexia, and then from all tissues invaded by proliferating lymphoid 
cells (Plowright, 1968). Edington and Patel (1981), working with 
rabbits as an experimental model, determined that the spleen is the 
target organ and primary site of virus replication. They postulated 
that the detection of an early cycle of replication indicates that 
MCFV has an early pathogenesis similar to that of other lymphotropic 
herpesviruses, i.e., Marek's disease virus (MDV) in poultry. However, 
in MD the replication in the bursa is followed by the production of 
infectious, cell-free virus from the feather follicle, whereas there 
has been no evidence of MCFV being produced in other than lymphoid 
cells, nor does horizontal transmission occur between either cattle 
or rabbits (Plowright, 1968). The target cell was determined by these 
same authors (Patel and Edington, 1980) as being associated with medium 
sized lymphocytes and not with the proliferative lymphoblastoid cells. 
A similar observation took place in MCFV infected cattle (Patel and 
Edington, 1981) and evidence exists for a latent state of MCFV in the 
bovine medium-size lyinphocyte. It was not possible either in cattle 
or rabbits to determine the lymphocyte subpopulation carrying the genome 
of MCFV (Patel and Edington, 1981). 
Bovine herpesvirus-4 (BHV-4). 
A large number of isolates recovered from diverse clinical syndromes 
as well as from clinically normal cattle in Africa, the Near East, 
Europe and Asia have been placed in the bovine herpesvirus-4 group 
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(WHO/FAO, 1976; Straub, 1978; Mohanty, 1980). The European and American 
isolates have been demonstrated to be serologically related to the 
strain Movar 33/63 (Bartha et al., 1966) which has been designated the 
prototype strain of the BHV-4 group·(Table 2). 
Bartha et al., in Hungary in 1966, isolated a herpes-type virus, 
Movar 33/63, from ocular discharges of calves that had developed a 
severe keratoconjunctivitis 2-4 weeks after recovery from pneumoenteritis 
due to bovine adenovirus type-4. The virus was non-pathogenic to 
calves and, with respect to keratoconjunctivitis, no etiological role 
could be attributed to the Movar isolate. A serologically related 
virus was isolated from tongue and palate material of a case of malignant 
catarrhal fever found in East Germany (Liebermann et al., 1967). 
The virus, designated Reims isolate, was nonpathogenic for calves, 
rabbits and mice. Luther et al. (1971) reported the isolation of a 
strain of herpesvirus different from other known bovine herpesviruses 
from calf kidney cell culture derived from a normal animal in England, 
This took place during the course of routine work in their laboratory 
on preparation of cell cultures. The isolate was called CK-54. This 
virus was similar to Reims and Movar isolates when analyzed by cross 
neutralization tests performed by reduction of 50% plaque titer. For 
all three of the isolates the conventional seroneutralization test was 
not sensitive enough to detect significant antibody titer, confirming 
previous observations of Bartha for Movar (Bartha et al,, 1966}. The 
isolation of this virus from apparently normal healthy cattle suggested 
Table 2. Isolates grouped within bovine herpesvirus-4 (BHV-4) 
Clinical disease/source from 
which virus was isolated 
Keratoconjunctivitis 
Respiratory disease 
Tongue and palate (malignant 
catarrhal fever-like case) 
Kidney 
Lymphoid tissues 
(leukocytes, lymph nodes 
and/or spleen) 
Denomination of 
the isolate 
Movar 33/63 (Reference 
strain) 
DN 599 
FTCl and 2 
ST-66 
Rheims 
Non-syncytia 
forming (NSF) herpesvirus 
CK-54 
BPX-11 
Orphan herpesvirus 
LK 
v 11 
Non-syncytia 
forming (NSF) herpesvirus 
Reticulosarcoma isolate 
BZD (Orphan herpesvirus) 
Geographical location 
and reference 
Hungary (Bartha et al., 1966) 
USA (Mohanty et al., 1971) 
USA (Smith et al., 1972) 
Russia (Bodon et al., 1971) 
E. Germany (Liebermann et al., 1967) 
Tanzania (Rweyemamu and Loretu, 
1973) 
England (Luther et al., 1971) 
Hungary (Belak and Palfi, 1974) 
Kenya (Plowright and Ferris, 
cited .by Alexander et al., 1957) 
Russia (Bodon et al., 1970) 
USA (Van der Maaten and Boothe, 1972) 
Tanzania (Rweyemamu and Loretu, 1973) 
Russia (Surin et al., 1969) 
South Africa (Alexander et al., 1957; 
Prydie and Coackley, 1959) 
Female Genital Tract 
Semen 
Skin 
Trigeminal ganglium 
DDV-71 
H. 1/80 
Unnamed 
Orphan herpesvirus 
NSF Herpesvirus 
2274 
Unnamed 
USA (Parks and Kendrick, 1973) 
USA (M. J, Van der Maaten, 
National Animal Disease Center, 
Ames, IA, USA. Personal 
Communication, 1980) 
Tanzania (Loretu et al., 1974) 
S. Africa (Alexander et al., 1957) 
Tanzania (Rweyemamu and Loretu, 
1973) 
USA (Reed et al,, 1977) 
USA (Homan and Easterday, 1980a) 
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the possibility of latency of the virus for long periods. A similar 
isolation from the kidney of a 2 month-old calf showing no clinical 
signs was reported by B:lak and P£lfi (1974) in Hungary. This strain~ 
BPX/ll~showed very low antigenicity in rabbits and failed to infect 
two calves. They reported serological relationship with Movar 33/63 
as demonstrated by serum neutralization. 
Three isolates of bovine herpesviruses antigenically related to 
Movar were reported in Russia. One of these strains~-LK -(Bodon 
et al., 1970) was isolated from leukocytes of calves with respiratory 
disease but no data were presented about experimental pathogenicity. 
The other strain - ST/66 - (Bodon et al., 1971) was recovered from the 
pharynx, pleura, nasal cavity and lymph nodes of a calf with broncho-
pneumonia. In this case, when young cattle were inoculated intra-
tracheally, animals developed signs of pyrexia, rhinitis and conjuncti-
vitis. The third Russian isolate, reported by Surin et al. (1969), 
was recovered from the axillary lymph node of a cow affected with 
lymphosarcoma of reticular cells. Rabbits, guinea pigs and mice 
inoculated intravenously and intramuscularly with the virus failed to 
reproduce any disease. 
Agents similar to Movar 33/63 have been isolated in Africa. 
These African isolates constitute a group generically designated "bovine 
orphan herpesviruses" due to their apparent lack of pathogenicity for 
cattle (Alexander et al., 1957; Gibbs and Rweyemamu, 1977b; Mohanty, 
1980). They have been known and described mainly in Tanzania, Kenya 
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and South Africa since well before the isolation of Movar 33/63 
(Weiss, 1963), but it was not until recently that their relationship 
to the Movar group was reported and their inclusion in the BHV-4 group 
proposed (Mohanty, 1980; Gibbs and Rweyemamu, 1977b), 
This group of "orphan bovine herpesviruses", whose African 
prototype strain was called BZD, was first described by Alexander and 
Haig in 1957, in South Africa, They isolated this virus on five different 
occasions from suspensions of skin nodules or lymph nodes of animals 
suffering from lumpy skin disease (Alexander et al., 1957). 
The widespread frequency of these orphan viruses among cattle in 
Africa is a striking feature of the group. From 27 specimens of field cases 
of lumpy skin disease, Prydie and Coackley (1959) isolated, in Kenya, 
4 "orphan" viruses. from skin lesions as well as from lymph nodes, They 
obtained two other isolations of similar "orphan" virus during serial 
passage of lumpy Skin disease in cattle. This mixing of "orphan" herpes-
viruses with the true etiological agent of lumpy skin disease, the pox-
virus denominated Neethling, constituted a common event in the character-
ization of that disease. In fact, the first "orphan" virus isolated by 
Alexander and Haig (Alexander et al., 1957) produced typical cases of 
lumpy skin disease with the 1st, 4th, and 8th tissue culture passage 
levels of the virus and doubtful reaction with the 15th passage level. 
The 26th and subsequent passage levels failed to produce any clinical 
reaction or antibodies to Neethling virus. It was later reported 
(De Lange, 1S59; Weiss, 1963) that a mixed culture of Neethling and an 
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"orphan" virus were transferred simultaneously through at least 15 
passages and that the poxvirus was eventually eliminated or outgrown by 
the "orphan" virus. 
During 1956 to 1962 orphan viruses were isolated in 10 of 77 
specimens from outbreaks of lumpy skin disease examined in South Africa 
(Weiss, 1963). In 7 of the 10 specimens, only orphan viruses were 
isolated, including one from a fresh salted hide. From the 3 other 
specimens, mixed cultures of orphan and LSD viruses were obtained. 
Furthermore, Alexander and Weiss, in 1959, isolated orphan viruses in 
3 out of 136 hides as reported by Weiss (1963). These hides originated 
from 3 different farms in the Northern Transvaal province of South 
Africa. 
Although orphan viruses have been repeatedly reported to be non-
pathogenic for cattle, sheep, goats, rabbits and mice and to have 
failed to produce neutralizing antibodies (Alexander et al., 1957; 
Haig, 1957; Prydie and Coackley, 1959; Capstick, 1959), it appears that 
the simultaneous inoculation of lumpy skin disease agent (Neethling 
virus) and an "orphan" bovine herpesvirus into cattle reduced the 
incubation period of lumpy skin disease but had no effect on its 
severity (Capstick, 1959). Alexander and Weiss, in 1959, cited by 
Weiss (Weiss, 1963), infected cattle with both viruses (orphan and 
Neethling). The cattle developed generalized lumpy skin disease. The 
orphan virus could be recovered from skin nodules between days 12 and 
26 post-infection and could be recovered sporadically from blood. 
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One of the animals was slaughtered 24 days after inoculation, and the 
orphan virus was isolated from lymph nodes, salivary glands, saliva, 
skin and muscle, but not from the gastrointestinal tract. 
Isolation of bovine herpesviruses related to orphan herpesviruses 
took place in Africa from several other sources. Haig (1957) isolated 
this virus from a case of vaginitis in cattle and Plowright and Ferris, 
in Kenya, (cited by Alexander et al., 1957), isolated a virus serolog- · 
ically indistinguishable from orphan viruses from uninoculated calf 
kidney tissue culture. 
Schiemann et al. (1971), working with Plowright and Jesset during the 
investigation of an outbreak of a severe disease in buffaloes at 
Serengeti National Park in Tanzania, isolated orphan viruses from the 
supraescapular, mesenteric and hepatic lymph nodes of 3 animals. The 
·isolate was non-pathogenic for rabbits and no neutralizing antibody 
activity could be detected. Furthermore, Kaminjolo, working in Kenya, 
in 1972, isolated an orphan-like herpesvirus from tumors of urinary 
bladders from several steers. Subsequently, Rweyemamu and Loretu (1973) 
reported the isolation of what they called non-syncytia forming (NSF) 
herpesvirus from cattle in Tanzania. These isolations were from a 
skin nodule suspected of Lumpy skin aisease, pharyngeal mucosa of a 
heifer with diarrhea, a tongue scraping for foot-and-mouth disease 
investigation and from the huffy coat layer of blood samples of animals 
with jaundice with possible cause of death due to chlorinated hydrocarbons. 
After further characterization of these isolates Rweyemamu and Loretu 
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concluded that these non-syncytial forming herpesvirus isolates were 
identical and indistinguishable from the African "orphan" herpesviruese. 
At the same time they called attention to the similar cytopathic effect 
of these isolates, Movar 33/63 and human cytomegalovirus. Nevertheless, 
they could not carry out any critical comparison with the European 
Movar 33/63 because of the impossibility of preparing antisera of good 
titer in rabbits for either Movar or NSF isolates. They suggested the use 
of a plaque reduction neutralization test. 
Loretu et al. (1974) isolated from bovine semen a non-syncytia 
forming herpesvirus that was homologous to the previously described 
isolates. The first reported isolation in America of a virus related to 
Movar 33/63 took place in 1971, when Mohanty and co-workers (Mohanty et 
al., 1971) isolated a herpesvirus (DN-599) from nasal swabs taken from an 
18-month-old steer with clinical symptoms of respiratory disease. They 
reported that experimental infection via the respiratory route caused 
overt respiratory disease in young calves (Mohanty et al., 1971, 1972). 
The inoculated calves developed severe respiratory disease accompanied by 
pyrexia, hyperpnea, dyspnea, cough, and profuse nasal discharge. 
Conjunctivitis was noticed in the majority of calves and some of them 
died. The virus was recovered from the nasal discharge of the affected 
animals for up to 17 days postinfection and from the lungs of those that 
died. The lungs of those that died had areas of consolidation, 
atelectasia and emphysema. Pasteurella multocida was also isolated 
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from these lungs (Mohanty, 1973). This virus was not neutralized by 
antisera to herpes simplex virus, IBRV, Movar 33/63, MCFV, Allerton, 
pseudorabies, BHV-2 and canine, equine, and avian herpesviruses (Mohanty 
et al., 1971,1972). Recovered calves did not develop neutralizing anti-
bodies to DN-599 virus (Mohanty et al., 1972) nor were antibodies en-
countered in 84 sera from Maryland cattle (Mohanty et al., 1971). An anti-
body response was not detected in calves, goats, rabbits, chickens and rats 
after multiple inoculations even when adjuvant was used in some cases 
(Mohanty, 1973). It was demonstrated later that antibody titers in fact 
do rise, and can be demonstrated by ferritin conjugated IgG or by immune 
electron microscopy (Mohanty, 1975). The indirect immunofluorescence test 
was also demonstrated to be very sensitive for detection and assay of 
antibodies to DN-599 (Sass et al., 1974). 
Smith and co-workers (1972) isolated a bovine herpesvirus from the 
tissues (ulcers of the larynx and pharynx and retropharyngeal lymph nodes) 
of 4 of 19 steers from an outbreak of respiratory disease characterized 
by hemorrhagic necrotizing tracheitis. The agent, called FTC, was similar 
in many respects to the Movar 33/63 and DN-599 isolates. Subsequent 
experimental infection of colostrum-deprived calves with both FTC and 
DN-599, caused little or no clinical illness. Repeated injections of 
virus suspensions into calves, goats, and rabbits elicited very little 
or no measurable neutralizing or complement fixing antibody. 
Parks and Kendrick (1973) isolated a herpesvirus from the uterine 
exudate of a dairy cow with metritis. The infected animal was one of a 
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herd of 1800 dairy cows that had experienced an abnormal incidence of 
postpartum metritis. The virus had no serologic relationship to several 
known herpesviruses. When injected into young animals, (Kendrick et al., 
1976) intranasally, intramuscularly and in the conjunctival sac, no 
reisolation of the virus was possible and serum neutralizing antibody 
could not be identified. The only response was a very uniform peak of 
pyrexia in all the animals between days 7 and 10 postinfection. The 
possibility of some role of this isolate (DDV-71) in bovine fetal disease 
was investigated by inoculation into bovine fetuses of various gestational 
ages. This resulted in the death of some fetuses in the 3rd and 4th 
months of gestation. Some fetuses in the 3rd and 4th month and all older 
than 4 months survived the inoculation. These fetuses experienced a 
lymphoreticular activation. Virus was isolated in 4 fetuses, from lung 
or amnionic fluid. The fact that only fetuses of 3 to 4 months were 
affected made unlikely any important role of this virus in bovine 
abortions, because most undiagnosed bovine abortions occur in mid-
gestation (Kendrick et al., 1976), 
Potgieter and Mare' (1974) demonstrated an antigenic relationship 
among the isolates DN-599, FTC and Vll. This last isolate was a herpes-
virus isolated by Van der Maaten (cited by Potgieter and liar~, 1974) 
from leukocytes and lymph nodes of a lymphosarcomatous cow in Iowa. 
They could demonstrate, by reciprocal virus neutralization and indirect 
fluorescent antibody test, that the 3 isolates were antigenically related. 
They were successful in demonstrating neutralizing activity of the 
specific antisera by using plaque reduction (50%) neutralization test 
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with an incubation of 4 C overnight followed by 2 hours at room 
temperature. They verified that the rate at which DH-599, FTC and 
Vll viruses were neutralized by specific antiserum was exceptionally 
slow but relatively high antiserum titers were observed. 
Smith published in 1976 the results of his studies on the serologic 
relatedness of several isolates related to Movar. He claimed to have 
modified standard serologic techniques which enabled him to group these 
agents. Details of these modifications were not published. As a result 
of this analysis, he concluded that the European isolates Movar 33/63, 
CK-54 and BPX/11, and the American isolates DN-599, FTC, DDV-71 and Vll 
were serologically related and proposed the establishment of a Bovid 
herpesvirus-5 group in which would be included all of these isolates. 
He reported that by his modified serologic techniques he was able to 
detect subgroup differences within this group. Further details about 
these differences were not published. 
Other isolates of BHV-4 have been reported in America. One of them 
was made by Van der Maaten from a uterus of a normal cow (M. J. 
Van der Maaten, National Animal Disease Center, Ames, Iowa, USA, Personal 
communication, 1980). This isolate was serologically indistinguishable 
from Vll and DN-599 (Osorio and Reed, Vet. Med. Res. Inst., Iowa State 
University, Ames, Iowa, unpublished data 1980). Eugster (1978) isolated 
a virus from the feces of a cow with diarrhea. This virus was serologi-
cally identical to DN-599. In experimental inoculation of cattle with 
this fecal strain the only clinical sign noted was a fever after 3 to 
4 days postinoculation. Virus was recovered from the nose 2 to 
10 days postinfection. 
Reed et al. (1977) isolated a strain (3374) serologically similar 
to DN-599 from 2 separate enzootics of mammary pustular dermatitis. 
This same author reported the isolation of a similar agent from a 
bovine fetus aborted in the 6th month of gestation (Reed et al., 1979). 
The virus was mixed with a cytopathic strain of bovine viral diarrhea 
virus. 
In 1980, Krogman (Krogman, L., 1980. Host responses of calves to 
a BHV-5 Herpesvirus. Master of Science Thesis, South Dakota State 
University, Brookings, South Dakota, USA) studied the possible reacti-
vation of DN-599 after corticosteroid treatment. Experimental infection 
of cattle was performed by intratracheal, intranasal and intradermal 
inoculation. During the period of acute infection no virus was detected 
from any source and in 2 of 4 inoculated calves mild respiratory signs 
were evident. After repeated dexamethasone treatments, she could isolate 
(post-mortem) virus from the thoracic lymph node of one of the calves, 
7 days after the last dexamethasone treatment. From another calf the 
virus was isolated from organ cultures of spinal cord and trigeminal 
ganglion after 5 days of incubation. This detection in neural ganglia 
took place almost 50 days post-dexamethasone treatment. The source of 
DN-599 used for this experiment was an isolate from South Dakota (77-4019) 
recovered from a pool of lung spleen and liver of a five-month-old· calf. 
During a survey to detect persistent BHV-1 in neural tissues, Homan 
and Easterday (1980a) reported the isolation of DN-599 virus from exvlant 
and cocultivation of trigeminal ganglia of 2 out of 43 abattoir 
slaughtered cattle. 
On the basis of the similarities among all these European, African 
and American isolates it has been proposed that all of them be placed 
in the bovine herpesvirus-4 group with Movar 33/63 as prototype reference 
strain (WHO/FAO, 1976; Gibbs and Rweymamu, 1977b; Mohanty, 1978; Straub, 
1978). The relationship between the American and European strains has 
been confirmed by serology and widely published (Smith, 1977). Although 
the same relationship was reported between African and European isolates, 
no details about the serological procedures used have been published 
(Gibbs and Rweyemamu, 1977b; llohanty, 1980). 
All of the isolates have connnon characteristics that constitute the 
features of the BHV-4 group. These are: 
1) Morphology and physicochemical characteristics of herpesviruses 
which are indistinguishable from other members of the family Herpes-
viridae. 
2) Ability to grow to high titer in cell monolayers derived from 
bovine tissues but also in unestablished kidney cell cultures of several 
other species (Bartha et al., 1966; Luther et al., 1971; Sass et al., 
1974; Gibbs and Rweyemamu, 1977b). 
3) The cytopathic effect is slow when compared with BHV-1 and 
BHV-2 and is apparent after 3-4 days of incubation. Although the time 
of appearance of CPE can be shortened, it will be always greater than 
24 hours. 
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4) Most authors agree that BHV-4 group do not produce syncytia, 
with the exception reported by Luther et al. (1971) for the isolate 
CK-54. 
5) In most cases there is no evidence to support the role of the 
isolates as primary etiological agents and, with some exceptions, the 
experimental inoculation of cattle with these isolates do not produce 
any symptoms. Two American isolates: DN-599 and FTC (Mohanty et al., 1971; 
Smith et al., 1972) and a Russian isolate: ST-66 (Bodon et al., 1971) 
demonstrated experimental pathogenicity when inoculated into cattle. 
6) None of the isolates produced disease in laboratory animals. 
The species assayed by different workers were rabbits, guinea pigs, 
hamsters, rats, neonatal and adult mice and chickens (Gibbs and Rweyemamu, 
1977b). 
7) All of the isolates demonstrated limited ability to induce 
detectable titers of neutralizing antibodies, in cattle and rabbits, by 
the standard serum neutralization assays. However, high titers of 
antibodies are present in this sera, when assayed by other means such 
as indirect immunofluorescence (Sass et al., 1974) and immunoelectron 
microscopy (Mohanty, 1975). Potgieter and Mare (1974) demonstrated that, 
for three American isolates, the specific neutralization of the viruses 
was extremely slow. To explain the lack of SN titers, they postulated 
the induction of BHV-4 of low avidity antibodies, which do not 
irreversibly inactivate viral infectivity. 
8) The members of the BHV-4 group are characterized by a widespread 
distribution, having been reported in Africa, Europe, America and 
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recently in the Near East (Erhan and Onar, 1977). Potgieter and 
Aldridge (1977) demonstrated antigenic homogeneity among 3 American 
isolates originating from 3 very distinct points of the United States. 
Ungrouped bovine herpesviruses 
There are still some isolates of bovine herpesviruses that 
demonstrate some different characteristics from the members of the 
four groups previously described. 
In the U.S.A., Van der Maaten and Boothe (1972) isolated a strongly 
cell-associated syncytial herpesvirus from leukocytes of 2 cattle with 
lymphosarcoma. When examined by electron microscopy, this virus 
demonstrated herpes viral structure. In tissue culture, syncytia developed 
but intranuclear inclusions were not encountered. Experimental animals 
inoculated by a variety of routes with this virus remained normal. 
Calves were infected with no apparent disease, but the virus was 
reisolated from the circulating leukocytes of these calves 4-12 months 
post-inoculation. Sera from the original herd demonstrated high titers 
of antibodies by the IFA test for this virus. No evidence linked this 
herpesvirus with the lymphoid neoplasm of cattle, Although the authors 
postulated some possible relationship with BHV-2, because of similar 
cultural characteristics, there is no supplementary information in the 
literature about a comparison between both viruses. 
Finally, there is a group of South African viruses whose isolation 
~ 
by Mare and Van Resnburg (1961) and by Theodoridis (1978) took place 
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during an investigation of the viral etiology of a regional reproductive 
disease known as "Epivag syndrome" (epididimitis-vaginitis). These 
viruses share several features with BHV-4, principally their slow 
cytopathic effect and induction of low avidity neutralizing antibodies. 
These viruses have been described (Theodoridis, 1978) as producing 
many enlarged cells (giant cells) in infected tissue cultures, when 
stained with hematoxylin-eosin. This characteristic was the reason 
by which some authors (Mohanty, 1980) described them as the cyto-
megalovirus of the bovine species. The existence of the bovine cyto-
megalovirus was inferred by Schiefer (1974) when he found cytomegalic 
inclusion bodies by histopathology in an aborted fetus in Canada. He 
found dense particles, believed to be virus, when observing the cytoplasm 
of these cytomegalic cells by electron microscopy. 
The Epivag-related slow herpesviruses were mainly isolated from 
reproductive tissues: vagina, semen, testicles and placenta. Sometimes 
they were mixed with IPV virus and their experimental pathogenicity 
consisted of a mild anterior vaginitis. The pathological significance 
of these viruses becomes apparent when inoculated together with IPV 
virus (Theodoridis, 1978). There are no references in the literature 
concerning their comparison with BHV-4 group members or their character-
ization as bovine cytomegalovirus. 
Persistent Infections By Herpesviruses 
A persistent infection is defined as one in which virus (or at 
least the viral genome) is conserved in the host for long periods of 
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time (Fenner, 1974). A chronic infection is a persistent infection 
in which infectious virus is present and can be recovered by conventional 
virological methods from appropriate tissues at any time (Fenner, 1974). 
A latent infection is a persistent infection in which infectious virus 
is not present, or is present only intermittently in tissues harboring 
the viral genome in a "reactivable" state (Stevens, 1978). 
The herpesviruses, particularly as exemplified by herpes simplex, 
have long been considered to be the classic examples of latent viruses. 
The herpesviruses have been divided (Stevens, 1978) into three subgroups 
according to the tissue harboring latent viruses (Table 3): neurotropic 
herpesviruses, those that are associated principally or exclusively with 
nervous tissues; lymphotropic herpesviruses, are those that persist in 
association with lymphoid tissue and epitheliotropic herpesviruses are 
those persisting in epithelial tissues. 
Persistence of herpesviruses in nervous tissue 
Herpes simplex virus (RSV) represents a well-studied member of the 
neurotropic group. The latent infection established by RSV appears to 
be specific for nervous tissues, since after inoculation of large doses 
of virus intravenously, only nervous tissues were found to harbor the 
virus (Stevens, 1978). Viral genetic information can be found only in 
neurons when in situ hybridization techniques are applied to latently 
infected ganglia (Stevens, 1975). The state in which the viral genome 
persists in these neurons is not definitely known but there is evidence 
* Table 3. Herpesviruses grouped by organ or tissue in which they persist 
NERVOUS TISSUE 
(NEUROTROPIC HERPESVIRUSES) 
LYMPHOID TISSUE 
(LYMPHOTROPIC HERPESVIRUSES) 
EPITHELIAL TISSUE 
1< 
Herpes simplex virus types 1 & 2 
Herpesvirus simiae and others 
simian herpesviruses 
Bovine herpesvirus - lt 
+ Pseudorabies virus' 
Epstein - Barr virus 
Murine cytomegalovirus 
Marek's disease virus 
Herpesvirus sylvilagus 
Equid herpesvirus 2§ 
Lucke's carcinoma virus of the frog 
Epstein - Barr virus 
Taken from Stevens (1978) with additions. 
t from McKercher, 1973. :j:Taken 
Taken from Patel and Edington, 1981, 
§ 
Taken from Coggins and Gleeson, 1980. 
Herpesvirus ateles 
Herpesvirus saimiri 
Malignant catarrhal fever 
Human cytomegalovirus 
'(possible) 
:j: 
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that it does not persist as replicating virus (Stevens, 1978). The 
postulated non-replicating virus would persist as an entire virion or 
as viral DNA only. 
The possible relevance of some special features of the viral genome 
of herpesviruses for their need of integration for latency has been 
postulated by Ritchie and Timbury (1980) who remark that similarities 
exist between the structure of HSV-DNA and that of a transposable element 
(transposon). These unique sequences bracketed by repeated sequences 
exist for all the herpesviruses studied and could stand for a molecular 
explanation of establishment of latency as well as reactivation. In the 
case of HSV, integration into cellular DNA is not a required mechanism 
for perpetuation of infection, since neurons do not divide. 
The mechanism by which the latent infection is maintained has not 
been defined. Two major hypotheses have been proposed: the "dynamic 
state" and the "static state" hypotheses. The dynamic state hypothesis 
(Hill and Blyth, 1976) suggests that virus replication and shedding from 
infected ganglia is occurring continuously but at a slow rate. The 
virus migrates to the skin and produces microfoci of infection but the 
host's immune response, if uncompromised, can control the degree of 
virus-induced cytopathology and no clinical disease occurs. Support for 
this hypothesis comes from observations that virus shedding does occur 
intermittently or continuously in the absence of visible lesions (Hill 
and Blyth, 1976). 
The static state theory suggests that the virus is present in the 
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ganglia in some unknown state, either integrated or free, but not 
replicating, possibly because the specific neurons harboring the virus 
lack a functional transcriptase required for replication (Roizman, 1974) 
or because of some immunological control of replication (Lehner et al., 
1975). Following some reactivation stimulus, altering the biochemical 
or immunological balance, the virus migrates centrifugally along the 
axon to initiate an active site of replication in epithelial cells. 
Persistence of herpesviruses in lymphoid tissues 
Gammaherpesvirinae (Epstein-Barr virus group) and Betaherpesvirinae 
(cytomegalovirns group) present evidence for association with lymphoid 
cells during persistent infection (Stevens, 1978). In the first case, 
the evidence is strong. The well-characterized Epstein-Barr virus (EBV) 
was initially found in a persistently infected lymphoblastoid cell line. 
In fact, lymphoblastoid cell lines can be established from essentially 
any person with positive EBV serology or by infecting in vitro cultures ----
of lymphocytes derived from seronegative individuals (Ho, 1981). These 
cell lines constitute "immortalized" cultures that carry the viral 
genome; all are characterized as being of B-cell origin (T cells do 
not possess viral receptors). 
Unlike tissues carrying herpes simplex virus, Epstein-Barr virus 
can not be recovered directly from lymphocytes at the time they are 
taken from the infected individual. Viral replication takes place only 
following the stress or derepression of in vitro cultivation 
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(Stevens, 1978). However, two antigens,, Epstein-Barr nuclear antigen 
(EBNA) and membrane antigen (MA), are present in latently infected 
cells examined directly after removal from the patient. The different 
cell lines carrying the EBV genome differ in the degree to which the 
virus is expressed, varying from a very limited expression to replication 
of infectious virus (Ho, 1981). 
The state of the viral DNA in latently infected cells is well-
understood in the case of EBV. The genetic information for EBV exists 
in lymphocytes in two forms: a circular, extrachromosal plasmid of 
length equivalent to that of an intact EBV genome and an integrated 
form of unknown length (Adams and Lindahl, 1975). EBV is unique among 
human viruses in that it produces disease by immortalizing or trans-
forming cells. Thus, the lymphocytes transformed by EBV multiply like 
tumor cells and a small number of lymphocytes can produce cell-free 
virus capable of infecting other lymphocytes. This infection and trans-
formation by EBV of antibody producing B cells results in polyclonal 
expansion with many types of antibodies produced. The cells producing 
heterophil antibodies to sheep or horse red blood cells are always 
affected and cause the increase of these antibodies in EBV-infected 
patients (Ho, 1981). 
The relationship of Betaherpesvirinae with lymphoid cells is less 
clear than that of the EBV group. There is as yet no concrete evidence 
that human cytomegalovirus (HCMV) can even infect lymphocytes. Although 
HCMV can be detected in the huffy coat cells it presently is unclear in 
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which leukocyte fraction HCMV resides. Rinaldo et al. (1977) isolated 
HCMV from both mononuclear and polymorphonuclear leukocyte fractions. 
Virus was not detected in washed erythrocytes, plasma or leukocyte 
lysates. 
Lang and Noren (1968) first detected HCMV in association with 
leukocyte cells in infants infected congenitally with HCMV. This was 
the basis for a further hypothesis regarding the relevance of latently 
HCMV-infected lymphoid cells in organ transplantation and post-transfusion 
infections (Lang, 1972). In fact, Lang proposed that since transfused 
individuals receive unmatched leukocytes, this could constitute an 
in vivo mixed lymphocyte reaction with consequent enhanced replication 
of lymphoid elements. When the donor or recipient is carrying HCMV 
in his lymphocytes, it would result in a reactivation of the virus, 
with the expression of clinical disease. Joncas et al. (1975) 
reported the detection by DNA-DNA reassociation kinetics of unexpressed 
HC!fV genome in an EBV positive lymphoblastoid cell line which was 
established from a 9-month male child with congenital defects from whom 
was isolated cytomegalovirus. Furthermore, Pagano (1975) found several 
genome equivalents of HCMV DNA in the huffy coats of one of three blood 
donors but it is not known what cells they were in. 
Plotkin (1979) reported a line of B lymphoblasts that were permissive 
for HCMV. Ho (1981) reported that several attempts to infect normal as 
well as B or T lymphocyte cell lines with HCMV resulted in no infection, 
incomplete infection, or a small amount of virus replication, but no 
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evidence of viral persistence or transformation after freshly donated 
lymphocytes were infected. 
Other members of the Betaherpesvirinae group show more evidence 
than HCMV for lymphoid-associated persistence. Murine cytomegalovirus 
(MCMV) establishes a special relationship with B lymphocytes in the 
mouse. Virus attenuated by passage through cell cultures can establish 
a latent infection in B lymphocytes of neonatal mice. The latent 
infection can be demonstrated by cocultivation on allogeneic fibro-
blasts or by molecular hybridization (Hudson, 1979; Wise et al., 1979), 
Explants of abdominal lymph nodes and spleens of chronically infected 
mice resulted in reactivation of MCMV. Unattenuated virus will produce 
latent infection in B lymphocytes, T lymphocytes and macrophages, and 
other cells may be involved as well (Ho, 19~1). For now, latent MCMV 
infection can only be defined operationally; it is not possible to 
demonstrate lytic virus by routine laboratory methods and additional 
measures of activation, such as treatment with immunosuppressants or 
cocultivation, are needed. 
Nothing is known yet about the molecular basis of latency of MCMV; 
particularly about the state of viral genome and limitation of its 
expression. A big difference between EBV (Gammaherpesvirus) and MCMV 
(Betaherpesvirus) is that the lesions of MC!'!V were not demonstrated to 
be the result of lymphocyte infection (Hudson, 1979). 
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PART I. EXPERIMENTAL INFECTION OF CATTLE WITH BOVINE HERPESVIRUS-4: 
EVIDENCE FOR A LYMPHOID-ASSOCIATED PERSISTENT INFECTION 
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SUMMARY 
A strain of bovine herpesvirus-4 isolated from cases of mammary 
pustular dermatitis has been used for experimental infection of cattle. 
This strain is serologically indistinguishable from the group proto-
type Movar 33/63 and from strain DN-599. Serologically negative cattle 
were infected intravenously or by simultaneous intranasal, intravenous, 
intramammary (via teat channel) and intradermal inoculations. All 
isolated cattle seroconverted. No clinical signs or lesions were 
evident, except for a dermal lesion corresponding with one intradermal 
inoculation point. Virus was recovered from the dermal lesion and 
was excreted in milk for 17 days. Virus was recovered from esophagus-
pharyngeal ~luid at 9 and 13 days post-inoculation. At different times 
of slaughtering (2 to 14 months post-inoculation) virus was recovered 
from cocultures with bovine lung cells and/or explant cultures of 
lymph nodes, spleen, tonsils, and in one case, kidney. In 2 of the 
cattle, the virus was recovered repeatedly throughout one year from_ 
peripheral blood leukocytes by cocultivation with bovine lung cells. 
The number of infectious leukocytes, as determined by Infectious 
7 Centre Assay, ranged from less than 1 to 6 infectious cells per 10 
leukocytes. 
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INTRODUCTION 
The type .4 of bovine herpesvirus also is referred to as Bovid 
herpesvirus-4 (BHV-4) and includes a large number of isolates recovered 
from diverse clinical diseases as well as from healthy cattle (WHO/FAD, 
1976; Straub, 1978). Members of this group are geographically wide-
spread and have been reported in Africa (Alexander et al., 1957.; 
Rweyemamu and Loretu, 1973), in Europe (Bartha et al., 1966; Liebermann 
et al., 1967; ·Luther et al., 1971; B~lak and P£1£i, 1974), and in 
America (Mohanty et al., 1971; Smith et al., 1972; Kendrick et al., 1976; 
Reed et al., 1977). In most of the cases, serological relationship to 
the European isolate Movar 33/63 (Bartha et al., 1966) has been 
reported (Smith, 1977; Gibbs and Rweyemamu, 1977). This strain con-
stitutes the prototype reference for the group (WHO/FAO, 1976). 
Distinctive features of the BHV-4 group are a slow cytopathic 
effect (CPE) with no syncytium development (Gibbs and Rweyemamu, 1977) 
and a humoral immune response characterized by the production of low 
avidity neutralizing antibodies which are barely detectable by standard 
seroneutralization assays (Potgieter and Mare', 1974). 
Although a possible role in respiratory disease has been reported 
(Mohanty et al., 1971; Smith et al., 1972) most of the isolates of BHV-4 
group exhibited a general failure to elicit clinical disease by 
experimental inoculation of cattle and laboratory animals (Alexander 
et al., 1957; Liebermann et al., 1967; Luther et al., 1971; Schiemann 
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et al., 1971; B~lak and Palfi, 1974) and the pathogenic role of the 
group is still ill-defined. 
The frequency with which members of the BHV-4 group have been 
recovered from tissues, mainly kidney, of apparently normal healthy 
cattle (Alexander et al., 1957; Luther et al., 1971; Belak and P~lfi, 
1974) suggested the possibility that these viruses could establish 
latency for long periods of time (Bllak and Palfi, 1974). The 
isolation of BHV-4 in 2 of 44 trigeminal ganglion explants was reported 
in a survey to detect naturally occurring latent bovine herpesvirus 
infections in neural tissue of abattoir cattle (Homan and Easterday, 
1981). These authors inferred that BHV-4 could establish neural latency. 
The present study was designed to characterize the experimental 
infection of cattle with a strain of BHV-4 isolated from cases of 
mammary pustular dermatitis in Iowa and South Dakota (Reed et al., 
1977). This isolate is serologically indistinguishable from the 
prototype strain Movar 33/63 and the DN-599 isolate (Reed et al., 
1977). 
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MATERIALS AND METHODS 
Clinical and Virological Procedures 
Cell culture 
Bovine lung (BI.G) cells were grown in Eagle's minimum essential 
medium with Earle's salts (MEM) supplemented with 10% betapioprolactone 
treated fetal bovine serum (FBS), 0.16% sodium bicarbonate, 8 mM 
N-2-hydroethylpiperazine-N'-2-ethanesulfonic acid (HEPES) and antibiotics 
(100 I.U. pencillin, 100 ug streptomycin culfate and 100 ug kanamycin 
sulfate per ml). Cells were grown and maintained at 37 Cina humidified 
air atmosphere containing 5% carbon dioxide (co2). 
Virus 
The strain 3374 (Reed et al., 1977) of bovine herpesvirus was 
recovered from scrappings of udder lesions in bovine fetal spleen 
(BFS)_cells and was passed three times in BLG cells. The stock prep-
aration used for inoculation contained 107·8 median tissue culture 
infective doses (TCID
50
)/ml. 
Experimental animals 
Nine Hereford cattle from one herd were used in this experiment. 
All of them were serologically negative for 3374 strain of BHV-4, 
as determined by the indirect fluorescent antibody test. Five of the 
cattle were used to infect and four were held as uninoculated controls. 
The infected cattle were: two adult (6 years old) cows in lactation; 
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one 1-week-old calf born from a serologically negative mother, kept in 
isolation after de~ivery, and fed with colostrum for the first 3 days; 
and one pregnant cow (8 years old) that delivered a heifer calf while in 
isolation, 25 days after infection. In the latter case, the heifer calf 
remained in isolation in contact with the dam. The control animals were 
4 calves born from the same seronegative herd, placed in isolation 
immediately after delivery and fed with colostrum for the first 3 days. 
Inoculation procedure 
The 2 adult cows in lactation received a total inoculation dose 
of 5 x 107 "8 TCin
50 
each. The inocula were administered in both 
animals by various simultaneous routes, as follows: 2 ml of the stock 
virus suspension was inoculated into the mammary gland, via teat 
channel (0.5 ml each quarter); 1 ml was inoculated intradermally in 
the skin of the udder (0.25 ml into each of 4 sites) and 1 ml was 
inoculated intravenously. The 1-week-old calf and the pregnant cow 
were injected with 107"5 TCin
50 
each, intravenously. 
Clinical observation and collection of specimens 
Clinical observation of inoculated and control cattle was carried 
out daily, beginning one week before infection, with collection of 
rectal temperatures and heparinized blood samples for hematology. 
Nasal, vaginal, ocular and rectal swabs as well as milk samples were 
collected for virus isolation. Esophagus-pharyngeal fluid samples 
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for virus isolation were collected by means of a cup probang. After 
day 30 post-infection (PI), clinical samples were taken with a 4 day 
frequency. Samples of serum were collected at inoculation time, at 
21 days PI, and every week thereafter. Total and differential 
leukocyte counts were made daily for 30 days PI. 
Necropsy 
The date of sacrifice for each of the inoculated animals is 
presented in Table 1. One uninoculated control calf was sacrificed 
simultaneously with cattle Nos. 1 through 4. The animals were killed 
by intravenous inoculation of sodium phenobarbital. 
At .necropsy, samples for virus isolation were taken from the 
following organs: lung, kidney, adrenal, lymph nodes (peripheral and 
visceral), spleen, liver, pancreas, tonsils, thymus, cervix, endometrium, 
and trigeminal and paralumbar ganglia. 
Virus isolation procedures 
The nasal, vaginal, ocular and rectal swabs were immersed in 
2 ml of MEM containing penicillin, streptomycin and kanamycin at a 
concentration 3 times higher than that described for cell cultures, 
plus 10 pg of amphotericin B per ml and vigorously shaken for 15 seconds 
prior to inoculation of 0.5 ml onto BLG monolayer cell cultures. 
The samples of whole milk and esophagus-pharyngeal fluid were 
diluted in a ratio 1:15 with MEM containg 3X regular antibiotics and 
Table 1. Experimental infection of cattle with bovine herpesvirus-4 
(Strain 3374): Experimental design, antibody conversion 
and viral recovery 
* Serology 
Number and 21 days PI Antibody 
type of Inoculation Preinoculation antibody titer at 
animal route antibody titer titer sacrifice 
1. Adult Simultaneous t Neg 80 320 
cow Inoculations: I.V. 
2. Adult I. MAMM: I.D. 5 160 640 
cow 
3. Calf I.V. Neg 80 80 
4. Adult I.V. Neg 160 160 
cow 
5. Heifer Contact Negll NT 80 
Controls 
6 None Neg Neg Neg 
through 
9 
* Data express the reciprocal of the indirect fluorescent antibody 
test titer. 
t 
I.V. =Intravenous; I. MAMM. = Intramammary; I.D. = Intradermal. 
tNT = Not tested. 
§MNC = mononuclear cells. 
II 
Preinoculation antibody titer stated for heifer No. 5 corresponds 
to birth time and following 32 ·days. 
~ 
Precise date of infection of heifer No. 5 is unknown. 
#NA = not applicable. 
Virus recovery 
during early 
post-infection 
period (31 days PI) 
Milk 
Milk and dermal vesicle 
Neg 
Esophagus-pharyngeal 
fluid 
Neg 
Neg 
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Virus assayed 
in leukocytes 
NTt 
NT 
NT 
(+) MNC 9 
(+) MNC 
Neg 
Necropsy 
(days PI) 
101 
132 
54 
401 
> 376 ~ 
NAii 
Tissues of 
post-mortem virus 
recovery 
Lymph nodes & spleen 
Lymph nodes, spleen 
& tonsils 
Lymph nodes, spleen, 
tonsils & kidney 
Lymph nodes & spleen 
Lymph nodes & spleen 
None 
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amphotericin B. Two ml of this dilution was inoculated onto BLG 
monolayer cell cultures. These were observed daily for the presence 
of CPE and were discarded if negative after 14 days. 
All solid tissues taken at necropsy were washed in MEM and cut 
3 into 1-5 mm pieces. Explant cultures of all the tissues were established 
by culturing these pieces in MEM supplemented with 10% FBS and 3X regular 
antibiotics and amphotericin B. The explant cultures were maintained 
at 37 C in a humidified air atmosphere containing 5% co2 , with medium 
changes twice a week. Samples of culture fluid were tested for 
infectivity on BLG cells every third day. 
For the preparation of cocultures, the constituent cells of tissue 
3 fragments (1-3 mm ) of lung, kidney, adrenal, tonsil, pancreas, genital 
tract and ganglion were dispersed by trypsinization in 0.25% trypsin 
at 37 C. Trypsinization was in 3 consecutive steps of approximately 
5, 15 and 45 minutes, or until turbidity was noticed. All the visible 
particulate material was discarded, saving the supernatants rich in 
single cells. These cells were rinsed three times in MEM, centrifuged 
at 150 xg for 5 min. and suspended in MEM with antibiotics and 10% FBS. 
Each of these batches of cells was mixed with trypsinized BLG cells in 
proportions 1:2 and incubated as described for other cell cultures. 
The suspension of single cells of lymphoid organs other than tonsils 
(spleen, thymus and lymph nodes) was prepared by mincing the tissue 
samples and repeatedly aspirating the suspension through a 5 ml syringe 
until the tissue pieces were thoroughly dissociated. Large, 
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non-dissociated clumps of cells were allowed to settle out and the 
suspended single cells were saved and rinsed 3 times in MEM, and Processed 
as described above for other cell types. 
Cell-free homogenates from the different tissues were prepared by 
mechanical disruption (Stomacher Blender, UAC House, London, UK) and 
further homogenization by Ten Broeck tissue grinders of a 10% suspension 
3 
in MEM of 1-3 mm pieces of tissue, In some cases, three cycles of 
freezing and thawing were added as an additional step. A sample of 
0.5 ml of these homogenates was inoculated onto BLG monolayers, which were 
watched for CPE as described. 
Investigation of the virus in blood 
The association of the virus with blood elements was studied in 
two of the inoculated animals, Nos. 4 and 5 (Table 2), throughout more 
than one year of isolation post-inoculation. 
Samples of blood ranging from 10 cc to 100 cc were collected by 
jugular venipuncture in tubes containing preservative-free heparin 
(5 IU per ml of blood collected). Plasma and platelet fraction and 
packed red blood cell (RBC) fraction were separated by centrifugation 
at 100 xg for 20 min. Both fractions were assayed by inoculating 1 ml 
of each on BLG cells monolayers. 
The isolation of polymorphonuclear fraction (PMN) was as described 
by Roth and Kaeberle (1981). After centrifugation of the blood sample 
at 1,000 xg for 20 minutes, the plasma, huffy coat and top few mm of 
Table 2. Isolation and quantitation of BHV-4 associated with peripheral blood leukocytes 
in experimentally infected cattle 
* Blood Fraction Virus Titer in MNC 
Animal Days t Plasma & Total 
No. PI Platelets RBC PMN MNC MNC Adherent Non-adherent 
Cow No. 4 13 Neg Neg Neg 
t 
NT + NT. NT 
20 Neg Neg Neg + NT NT NT 
52 Neg Neg Neg + 0.37 NT NT 
186 Neg Neg Neg + 0.08 NT NT 
386 Neg Neg Neg + 0.59 NT NT 
Reif er 130 Neg Neg Neg + 0.41 0.16 0.29 
No. 5 247 Neg Neg Neg + 0.36 Neg 0.45 
330 Neg Neg Neg + 0.19 0.24 0.33 
Controls: 
Calves Nos. 6 
thru 9 NA§ Neg Neg Neg Neg NT NT NT 
,, 
The titer of BHV-4 in mgnonuclear cell (MNC) fraction is expressed as the median of the number 
of focus forming units per 10 MNC as determined by Infectious Centre Assay. 
t Days post-infection. 
fNT = not tested. 
§NA = not applicable. 
..,. 
"' 
so 
packed RBC were aspirated and discarded. The packed RBC fraction was 
then measured and the erythrocytes in the suspension were lysed by 
adding two volumes of cold phosphate buffered (0,0132M, pH 7.2) deionized 
water with gentle mixing. Isotonicity was restored after 45 seconds by 
the addition of one volume of phosphate buffered (0.0132M pH 7.2) 2,7% 
NaCl solution. This preparation was poured into centrifuge tubes and 
centrifuged at 250 xg for 10 minutes. The supernatant fluid was poured 
off and the pellet of cells was resuspended in phosphate buffered saline 
(PBS), rinsed two times in that buffer and finally resuspended in Hanks 
balanced salt solution (HBSS) without Ca++ and Mg++. The cells were 
counted with a Neubauer's hemocytometer. A smear of the cells was made 
and stained with a modified Wright's stain (Marleco Diff-Quik, Dade 
Diagnostics Lab., Aguada, Puerto Rico). 
The PMNs were coated on BLG monolayers, in a ratio no higher than 
8 x 106 PMNs per 75 cm2 flask of BLG monolayer, incubated at 37 C and 
watched for CPE. 
For isolation of virus from the buffy coat layer, this fraction 
was aspirated after the centrifugation of blood at 1000 xg for 20 minutes 
and diluted in HBSS without Ca++ and Mg++ The suspension was counted 
and a smear of the cells was made and stained with modified Wright's 
stain. The buffy coat cells were inoculated onto BLG monolayers not 
6 2 exceeding the inoculum of 15 x 10 cells per 75 cm of BLG monolayer, 
When enrichment in mononuclear cells was required, a Ficoll-Hypaque 
flotation was used as described by Rouse and Babiuk (1974). The buffy 
51 
coat cells obtained by centrifugation of heparinized blood, suspended 
in 10 ml of HBSS without Ca++ and Mg++ were layered on 3 ml of 
3 Ficoll-Hypaque (density at 25 C, 1.077 g/cm ) (Ficoll-Pharmacia, 
Piscataway, NJ., Hypaque-Winthrop Lab., New York, NY), and centrifuged 
at 400 xg for 20 min at room temperature. The mononuclear cell (MNC) 
enriched (mainly lymphocytes) band was collected from the interface of 
plasma and Ficoll-Hypaque. These cells were washed once in HBSS without 
Ca++ and Mg++ and a total (hemocytometer) and a differential (stained 
smear) count was performed. The cells harvested by this technique 
contained always greater than 96% MNC. 
When isolation of adherent and non-adherent subpopulations from the 
MNC-enriched fraction was required, an additional rinse and resuspension 
of the MNC fraction in medium 199 (Grand Island Biological Co. (GIBCO), 
Grand Island, NY) was performed before the counts. For this separation 
the suspension of cells was placed in 60 mm plastic tissue culture Petri 
dishes and incubated for 2 hr with intermittent agitation at 37 C in a 
humidified atmosphere containing 5% co
2
, Non~adherent cells were removed 
by three :iligorous washes with medium 199 and were saved. The adherent 
cells were removed by gentle scrapping, pooled, and resuspended in 
medium 199. Both adherent and non-adherent cell fractions were counted 
as described. 
For Infectious Centre Assay (see below) the adherent cells were 
not removed from the 60-onn plastic Petri dishes, the assay instead 
was performed in situ after removal of the non-adherent fraction. 
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The number of adherent cells per plate was calculated by removing and 
counting the cells of a representative sample of plates. 
Infectious Centre Assay (ICA) 
Virus present in the MNC populations, as well as in adherent and 
non-adherent subpopulations was quantified by ICA. Dilutions of the 
MNC-enriched population and the non-adherent subpopulation were prepared 
either with HBSS without Ca++ and Mg++ or medium 199. The dilutions of 
the total MNC cells contained respectively 108 , 10
7 
and 10
6 
viable 
cells per ml whereas the dilutions corresponding to non-adherent cells 
7 6 5 contained 10 , 10 and 10 viable cells per ml. Immediately before 
plating on the monolayers, 0.1 ml of each dilution was thoroughly 
mixed with 0.5 ml of fluid agar overlay medium: MEM with 0.7% agar 
(Seaplaque, Marine Colloids, FMC Co., Rockland, MA), 5% FBS, 100 pg 
per ml of Protamine sulfate, 100 IU penicillin, 100 pg streptomycin sulfate 
and 100 pg kanamycin sulfate per ml) at 38-39 C and plated onto freshly 
seeded (2 hour prior) BLG cell monolayers in 60 mm tissue culture 
plastic Petri dishes. After this layer had solidified, a second 4 ml 
of agar overlay medium was added. Four monolayer cultures of BLG were 
used per dilution of total or non-adherent MNC suspensions. After 
incubation for 9 days, the monolayers were fixed with 10% formalin 
and stained with 1 percent crystal violet in 10% ethanol. 
The plates containing the adherent subpopulation were seeded 
with BLG cells, incubated 2 hrs at 37 C and coated with agar overlay 
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medium (4 ml). Plates were incubated 9 days, fixed and stained as 
described previously. After staining, foci of CPE were counted and 
6 expressed as focus forming units (FFU) per 10 MNC inoculated. 
Serology 
Identification of isolates All the isolates recovered from 
clinical samples, explants and cocultiyations were identified as 
BHV-4 by the indirect fluorescent antibody (!FA) test, as previous1y 
described (Reed et al., 1977). Slide cultures of BLG cells were 
inoculated with the isolate, incubated at 37 C until 50% CPE was 
observed, and then fixed in acetone for 1 minutes. Fixed slide 
cultures were flooded with a 1:20 dilution of a rabbit antiserum against 
the 3374 isolate of BHV-4 and incubated at 37 C for 1 hour. Slides 
were rinsed 3 times in 0.01 M (pH 7.2) phosphate-buffered physiologic 
saline solution (PBS), flooded with fluorescein-conjugated goat anti-
rabbit globulin (Cappel Lab., Downington, PA) and incubated at 37 C 
for 20 minutes. Slides were rinsed 3 times in PBS and mounted in 
borate buffered glycerin (pH 8.6) for examination by fluorescence 
microscopy. 
Antibody titers The !FA antibody titers of inoculated and control 
cattle were determined as described above with the following modifi-
cations: BLG slide cell cultures inoculated with the 3374 strain of 
BHV-4 were treated with dilutions of serums from inoculated and control 
cattle and then stained with fluorescein-conjugated rabbit anti-bovine 
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globulin (Cappel Lab., Downington, PA). All the serum samples from 
different times (pre and post-inoculation) corresponding to the same 
animal were titrated simultaneously. 
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RESULTS 
Clinical, Serological and Virological Observations 
Clinical findings and serology 
Inoculated animals showed no clinical symptoms other than increased 
body temperature (41..5-4'2 C) by day 4 and 5 PI. One of the cows that 
received intradermal inoculation of the virus in the udder developed 
a vesicular lesion at one of the 4 injection points. The lesion 
consisted of a circumscribed area of cutaneous congestion (3 nnn in 
diameter) that was apparent by day 6 PI and developed into a vesicle· 
48 hours later. No significant changes were detected in the total 
. and differential white blood cell counts carried out during the first 
30 days PI. 
Serology 
The serologic results are given in table 1. All inoculated animals 
developed specific antibodies by day 21 PI. These titers persisted 
and sometimes increased throughout the experiment. Heifer No. 5, 
which remained in contact with her infected mother, seroconverted 
42 days post-birth. 
Virus isolations 
Early post-infection period Table 1 sunnnarizes the viral 
isolation results. A homogenate prepared from a scraping taken from 
the single vesicular lesion in the udder of cow No. 2 produced BHV-4 
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CPE when inoculated onto BLG cell monolayers. 
Virus was isolated from the milk of cows Nos. 1 and 2 from 
day 2 PI to day 17 PI. The virus was isolated from esophagus-pharyngeal 
fluid only on days 9 and 13 PI from cow No. 4 which had been injected 
intravenously. Virus was not isolated from any fluid or mucous membranes 
of inoculated calves Nos. 3 and 5 or from the control calves Nos. 6,7, 
8 and 9. 
Isolation of BHV-4 from peripheral blood leukocytes Table 2 
s=arizes the results of vi·rus assay of each of the blood fractions 
of two of the animals (Nos. 4 and 5) at different times throughout a 
period of more than one year after infection. 
Early attempts to assay BHV-4 in leukocyte fraction were not 
successful because the initial high input of MNC or PMN produced toxic 
effects when cocultivated with BLG cells. Therefore, satisfactory 
results were not obtained until 52 days PI. 
The BHV-4 specific CPE developed in monolayers after incubation 
which was never less than 7 days and rarely longer than 10 days. When 
ICA technique was used, foci of BHV-4 CPE also were evidenced within 
this time range, It was not possible to keep the ICA monolayers in 
incubation longer than 10 days without appearance of degenerative 
changes in the BLG cells. ·we, therefore, fixed and stained the plaques 
at day 9 PI. 
The virus titer in the MNC population, as well as in the adherent 
and non-adherent subpopulations was low ranging from 0.08 to 0.69 
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FFU/106 MNC. Virus was isolated from none of the other cellular or 
plasma fractions of the blood of cattle Nos. 4 and 5, or from the 
blood elements of control calves Nos. 6,7, 8 and 9, when assayed at 
necropsy time. 
Post-mortem virus recovery Table 1 summarizes the tissues from 
which BHV-4 could be recovered in each of the infected animals at 
necropsy time. Virus was isolated from lymph nodes and spleen of all 
infected cattle (cattle Nos. 1 through 5), both from cocultures of 
dispersed cells with BLG cells and from explant cultures. 
In the cocultures, CPE characteristic of BHV-4 was detected 
after 6 ~o 8 days of incubation. Similar CPE was evident in BLG cells 
inoculated with supernatant fluid of spleen and lymph node explant 
cultures after incubation of the explant ranging from 6 to 16 days. 
In addition, outgrowths of cells (fibroblastic, in most cases) from 
these same explants became cytopathic between 12 and 20 days after 
explantation. 
The lymph glands from which BHV-4 was isolated included: sub-
maxillary, retropharyngeal, cervical, suprascapular, bronchial, 
mediastinal, mesenteric and prefemoral lymph nodes. Explants of kidney 
tissue from calf No. 3 shed BHV-4 as detected by assay of the super-
natant fluid and CPE in the outgrown cells was observed after 19 days 
of incubation. Virus was not isolated from explant cultures or from 
single cell cocultivation of any other tissue. 
All the organs sampled presented normal macroscopic characteristics 
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and no evidence for any pathologic alteration was found at necropsy of 
infected and control animals. Virus was not isolated from tissues of 
uninoculated control calves. The isolates recovered from milk, 
pharynx, udder, leukocytes, explant culture and cocultures were 
confirmed as BHV-4 by IFA tests. 
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DISCUSSION 
The results of these experiments, although they do not demonstrate 
a definite role in disease for the isolate 3374 of BHV-4 in cattle, 
demonstrate that this virus is capable of establishing a persistent 
infection. 
The single vesicular lesion which developed in the udder of one 
of the experimental animals was considerably less severe than the 
pustular dermatitis seen in the animals from which the strain 3374 
was isolated (Reed et al., 1977). 
Based on the circumscribed character of this dermal lesion and 
its location at one of the intradermal inoculation points, we believe 
that its development is more the consequence of intradermal inoculation 
rather than the expression of a true natural dermotropism of the 
virus. 
BHV-4 isolations from bovine skin and hides have been reported 
previously, especially during investigations of lumpy skin disease and 
p~eudolumpy skin disease in Africa (Alexander et al., 1957; Prydie and 
Coackley, 1959; Weiss, 1963; Rweyemamu and Loretu, 1973). Also, in 
these cases the dermal syndrome could not be reproduced by experimental 
inoculation of cattle and it was concluded that those BHV-4 isolates 
were "orphan" viruses (Alexander et al., 1957; Haig, 1957; Weiss, 1963). 
The most significant finding of this study was the demonstration 
that BHV-4 can establish a persistent infection in lymphoid tissues 
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and a prolonged viremia associated with the MNC fraction. The virus 
was detected in fluids of explant cultures and in the cocultures of 
lymphoid tissue, as well as in the blood, only after an incubation 
period which was never less than 7 days. At the same time, lysates 
of the original tissues failed to yield infectious virus. These two 
circumstances suggest a requirement for integrity of the cell to 
obtain expression of infectious virus. This persistent infection also 
is characterized by constant presence of circulating antibodies. 
Isolation of the virus from the MNC fraction of the blood in the presence 
of high titers of circulating antibody could also suggest that BHV-4 
in the blood is probably intracellular, and therefore protected from 
the action of antibody. 
The requisite of integrity of the cell and incubation to recover 
infectious BHV-4 is a characteristic we detected also in spleen tissues 
of persistently infected rabbits after experimental inoculation with 
BHV-4 (F. A. Osorio and D. E. Reed, Veterinary Medical Research 
Institute, Iowa State University, Ames, IA, submitted for publication, 
1982). This would suggest that the virus may persist in the lymphoid 
cell in a possible quiescent or latent state. Evidence for this 
feature has been found in, and extensively described for, other herpes-
viruses, specifically Betaherpesviruses such as murine cytomegalovirus 
(Henson et al., 1972; Wise et al., 1979; Ho, 1981) and possibly human 
cytomegalovirus as well as Gammaherpesviruses such as Epstein-Barr 
virus (Ho, 1981) and malignant catarrhal fever virus (Patel and 
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Edington, 1981). Alternatively, it also is possible that the virus 
is present in an actively replicating state, but in such a low titer. 
that it was undetectable in the cell-free homogenates. 
The virus associated with the MNC fraction of the blood, when 
titrated by !CA, was found in a very low titer not higher than 6 FFU 
7 (or infectious cells) per 10 MNC. These findings are similar to the 
titers observed in the MNC-associated persistent viremias described 
for equine herpesvirus-2 (Coggins and Gleeson, 1979) and human cyto-
megalovirus (Fiala et al., 1975). 
The fact that the virus is present in low titer in the huffy 
coat requires that a large sample (~ 50 cc) of blood be processed or 
some enrichment procedure be utilized. In this respect, the enrichment 
through Ficoll-Hypaque gradient proved to be highly efficient, con-
firming previous results (Howell et al., 1979) in viremias due to 
human cytomegalovirus and other viruses. 
We are still unable to define the type of MNC carrying the virus. 
Although the results presented in Table 2 show that BHV-4 was shed in 
higher titer by the non-adherent subpopulation (lymphocytes) of animal 
No. 5, the conclusion that lymphocytes constitute the target cell for 
BHV-4 would require more rigorous statistical analysis, employing more 
experimental animals. In addition, the possibility of contaminant 
subpopulations in each fraction can not be discarded and the fact that 
some subpopulations of lymphocytes can also be adherent (Benacerraf 
and Unanue, 1980) makes it desirable to characterize further the 
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cell type harboring_BHV-4. 
The herpesvirus of African malignant catarrhal fever (Bovid 
herpesvirus 3 - BHV-3) is also characterized by cell-associated viral 
infectivity, with virus recovery from lymphocytes and lymphoid tissues 
(Edington and Patel, 1981; Patel and Edington, 1981). Nevertheless, 
we could not detect in our experiments with BHV-4 any evidence of the 
extensive lymphoid proliferation that constitutes the distinctive 
feature of malignant catarrhal fever, Marek's disease, Epstein-Barr 
virus infections, and all the other diseases produced by members of 
the Gammaherpesvirus group (Ho, 1981; Patel and Edington, 1981). 
The association of BHV-4 with lymphoid organs ·and the MNC fraction 
of blood, with its consequent permanent transport through lymphatic 
and hematogenous routes for long periods of time, could explain the 
great diversity of tissues (and syndromes) from which BHV-4 has been 
recovered (Straub, 1978). Specifically, several isolates of BHV-4, 
although coming from very dissimilar diseases, were obtained from 
some type of lymphoid organ or peripherai biood ieukocytes. ·(Alexander 
et al., 1957; Prydie and Coackley, 1959; Bodon et al., 1970.: Schiemann 
et al., 1971; Smith et al. 1 1972; Rweyemamu and Loretu, 1973; M. J. Van der 
Maaten, National Animal Disease Center, Ames, IA, Personal communication, 
1980). 
Until more information becomes available about the definite 
pathogenic role of BHV-4, the presence of this virus in cattle used 
for immunological experiments can not be disregarded. In fact, the 
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close association demonstrated between BHV-4 and the bovine lymphoid 
tissues may have significant implications in immunological disorders 
of cattle. 
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ABSTRACT 
A strain of bovine herpesvirus-4 (BHV-4) isolated from bovine 
cases of mammary pustular dermatitis was used for experimental 
infection of rabbits. The strain is .serologically indistinguishable 
from the group prototype Movar 33/63 and from the American isolate 
DN599. 
Groups of rabbits were inoculated by various routes. Intravaginal 
and conjunctival inoculations resulted in vulvovaginitis and conjunc-
tivitis, respectively, and in shedding of virus. The rabbits sero-
converted for the virus, with high titers of antibodies (indirect 
fluorescent antibody test) that persisted throughout the experiment. 
Treatment with dexamethasone, beyond the acute infection, did not 
produce recrudescence of disease or shedding of the virus. Rabbits 
were killed at various times, from three to six months post-infection, 
and the virus was recovered from explant cultures of spleen and by co-
cultivation of spleen cells with bovine lung cells. 
These results demonstrate the usefulness of the rabbit as a model 
for studying the pathogenesis of BHV-4 infections in cattle. 
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INTRODUCTION 
The bovine herpesvirus 4 group (BHV-4) - also referred as 
bovid herpesvirus 4 - (WHO/FAD, 1976; Straub, 1978; Mohanty, 1980) 
includes a large number of isolates recovered from diverse clinical 
diseases as well as from healthy cattle. Members of this group are 
widespread and have been reported in Africa (Alexander et al., 1957; 
Rweyemamu and Loretu, 1973), in Europe (Bartha et al., 1966; Liebermann 
et al., 1967; Luther et al., 1971) and in the United States (Mohanty 
et al., 1971; Smith et al., 1972; Kendrick et al., 1976; Reed et al., 
1977). In most of the cases, serological relationship to the European 
isolate Movar 33/63 (Bartha et al., 1966) has been reported (Smith, 
1977; Gibbs and Rweyemamu, 1977) and this strain constitutes the 
prototype reference for the group (WHO/FAD, 1976). 
The members of the BHV-4 group produce a slow cytopathic effect 
(CPE) in tissue cultures, with no syncytium development, (Gibbs and 
Rweyemamu, 1977) and they evoke a humeral immune response characterized 
by production of low avidity neutralizing antibodies which are barely 
detectable by standard seroneutralizing (SN) assays (Potgieter and 
I 
Mare, 1974). 
Although a possible role in respiratory disease has been reported 
(Mohanty et al., 1971; Smith, et al., 1972) most of the isolates of 
BHV-4 group exhibited a general failure to elicit clinical disease by 
experimental inoculation of cattle and laboratory animals. All the 
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isolates of BHV-4 assayed have been reported apathogenic for rabbits, 
guinea pigs, hamsters, rats, neonatal and adult mice, and chickens 
inoculated by various routes (Alexander et al., 1957; Liebermann et al., 
1967; Luther et al., 1971; Schiemann et al., 1971; Mohanty, 1973; 
Belak and Palfi, 1974). 
In the experiments herein presented, we used an American strain 
of BHV-4 which was isolated from cases of mammary pustular dermatitis 
by Reed et al. (1977) and that is serologically indistinguishable from 
Movar 33/63 and DN599 isolates. Previous work in our laboratory 
demonstrated the ability of this strain to establish a lymphoid-
associated persistent infection after experimental inoculation of 
cattle (Osorio and Reed, 1982, Vet. Med. Res. Inst., Ames, Iowa, 
submitted for publication 1982). 
The purpose of the experiments that we report in this paper was 
to establish the feasibility of infecting rabbits with BHV-4. We 
were especially interested in determining if the rabbit could be used 
as a laboratory model to study the BHV-4 lymphoid association observed 
in cattle. 
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MATERIALS AND METHODS 
Inoculation Procedures 
Virus --
The strain 3374 (Reed et al., 1977) of bovine herpesvirus was 
recovered from scraping of udder lesions in bovine fetal spleen 
(BFS) cells and was passed three times in bovine lung (BLG) cells. 
The stock preparation used for inoculation contained 107 ' 8 median tissue 
culture infective doses (TCID
50
)/ml. 
Experimental animals 
Young adult white rabbits (2.5-3.0 kg) of either sex were 
purchased from a local commercial source and were housed in individual 
cages within an animal isolation room. All rabbits were free of anti-
bodies to strain 3374, as determined by indirect fluorescent antibody 
tests prior to inoculation. 
Experimental design 
Rabbits (n=20) were divided into six groups and inoculated as 
detailed in Table 1. 
The stock preparation of 3374 virus strain was inoculated 
according to the following procedures: The intravaginal inocula were 
spread in the anterior vagina and cervix; the marginal ear vein was 
used for intravenous inoculation; ocular inoculation was by instillation 
of the inoculum into the right conjunctival sac; intrapulmonar inocula 
Table 1. Experimental infection of rabbits with bovine herpesvirus-4 (strain 3374) 
Group Number of Rabbits Route of Inoculation Virus dose 
Used (TCID50
) 
1 6 intravaginal 107.5 
2 3 intravenous 107.8 
3 3 conjunctival sac 107.5 
4 2 intrapulmonary 107.8 
5 2 intradermal 107.8 
* 6 (control) 4 All the previous routes None 
* Each of the controls was mock-infected with a dose of Eagle's minimum essential 
medium (MEM) supplemented with 10%-Beta-propiolactone-treated fetal calf serum (FCS) 
equivalent to the infectious inocula, following the procedure of the inoculation route 
in each case. 
.... ..,.. 
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were injected at the level of the 6th intercostal space of the right 
hemithorax and the intradermal injections were applied in the shaved 
dorsal skin in four points of 0.25 ml each. 
Rabbits were observed for clinical signs of illness following 
virus inoculation. Conjunctiva!, vaginal and nasal swabs were 
collected for virus isolation daily during the first 32 days post-
infection (PI) and weekly thereafter. These samples were harvested 
by saturation of cotton-tipped swabs with conjunctival, vaginal or 
nasal fluids. 
Two rabbits of group 1 (Table 1) were killed at 89 days PI. At 
137 days PI all the remaining rabbits from the inoculated and control 
groups were treated daily with 4 mg of dexamethasone (Azium, Schering 
Corp., Kenilworth, N.J., U.S.A.) for 5 days. During the period of 
dexamethasone treatment and the following twenty days, daily samples 
for virus isolation were collected. At 180 days PI, all the animals 
were killed by electrocution. Samples of spleen were taken from all 
the rabbits, trigeminal ganglia were taken from rabbits of group 3 
(conjunctival inoculation) and group 6 (control), and paralumbar 
ganglia were taken from group 1 (intravaginal inoculation) and group 6 
rabbits. Viral isolation was attempted from these samples by homo-
genization (splenic tissues), explantation (splenic and nervous 
tissues) or cocultivation (splenic cells). Samples of serum were 
taken at 20, 137 and 180 days PI. 
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Cell culture 
Bovine lung (BLG) cells were grown in Eagle's minimum essential 
medium with Earle's salts (MEM) supplemented with 10% betapropiolactone 
treated fetal bovine serum (FBS), 0.16% sodium bicarbonate, SmM N-2-
hydroethylpiperazine-N'-2-ethanesulfonic acid (HEPES) and antibiotics 
(100 I.U. penicillin, 100 µg streptomycin sulfate and 100 µg kanamycin 
sulfate per ml). Cells were grown and maintained at 37°c in a humidified 
air atmosphere containing 5% carbon dioxide (co
2
). 
Virus isolation procedures 
The ocular, nasal and vaginal swabs were immersed in 2 ml of MEM 
containing antibiotics at the concentrations described above plus 10 µg 
amphotericin B per ml and vigorously shaken for 15 seconds prior to 
inoculation of 0.5 ml onto BLG monolayer cell cultures. The remaining 
sample was stored at -70 C until titration. The titrations were 
performed by serial 10-f old dilutions in MEM on BLG monolayer cultures 
in 24-well plastic tissue culture plates. Inocula were 0.1 ml/well and 
6 wells for each dilution. Virus titers were expressed as median tissue 
culture infectious doses (TCID
50
) per ml. 
Spleen and trigeminal ganglion samples for explant culture were 
washed in MEM, cut into 1-2 mm3 pieces, and cultured in MEM supplemented 
with 10% FBS, and antibiotics (including amphotericin B). Cultures 
were maintained at 37 C in a humidified air atmosphere containing 5% 
co2 . Samples of supernatant fluid were tested for infectivity on BLG 
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monolayers at 3-day intervals. 
Cell-free homogenates from these spleens were prepared as 10% 
suspensions in MEM by mechanical disruption (Stomacher Blender, 
UAC House, London, U.K.) and further homogenization by Ten Broeck 
tissue grinders. In some cases, three cycles of freezing and thawing were 
added as an additional step. A sample of 0.5 ml of these homogenates 
was inoculated onto BLG monolayers. 
Cocultivation of spleen cells was performed by mincing the spleen 
samples and repeatedly aspirating the suspension through a 5 ml syringe 
until the spleen was dissociated. Large, non-dissociated clumps were 
allowed to settle out and the suspended single cells were poured into a 
centrifuge tube. The cells were centrifuged at 1,500 rpm for 15 minutes, 
resuspended in 10 ml of MEM with FBS with antibiotics (including 
amphotericin B) and counted using a hemocy.tometer chamber. These cells 
were mixed with trypsinized BLG cells in a ratio spleen cells/BLG cells 
of 1:2. The cell mixtures were inoculated into small plastic flasks 
(25 cm2) and incubated in a humidified air atmosphere containing 5% 
co2 • All flasks were observed daily for cytopathic changes, 
Serology 
A) Identification of isolates: All the isolates recovered from 
swabs, explants and cocultivations were identified as BHV-4 by the 
indirect fluorescent antibody (IFA) test, as previously described 
(Reed et al., 1977). Briefly, bovine antiserums against the 3374 strain 
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of BHV-4 were obtained from cattle persistently infected with this virus 
in our laboratory (F. A. Osorio and D. E. Reed, Veterinary Medical 
Research Institute, Iowa State University, Ames, IA, submitted for 
publication, 1982). Those serums had IFA titers of 1:80-1:160. Slide 
cultures (Tissue Culture Chamber Slides, Lab-Tek Products, Division 
Miles Lab. Inc., Naperville, IL, USA) of 10-15th passage of BLG cells 
were inoculated with the isolates, incubated at 37 C until 50% CPE was 
observen, and then fixed in acetone for one minute. Fixed slide cultures 
were flooded with a 1:20 dilution of a bovine antiserum and incubated 
at 37 C for one hour. Slide cultures were rinsed three times in 0.01 M 
(PH 7.2) phosphate-buffered saline solution (PBS), flooded with fluores-
cein conjugated rabbit anti-bovine globulin (Cappel Lab., Downington, 
PA, USA) and incubated at 37 C for 30 minutes. Slides were rinsed three 
times in PBS and mounted in borate buffered glycerin (PH 8.6) for 
examination by fluorescence microscopy. 
B) Antibody titers: The IFA antibody titers of serums of the 
inoculated and control rabbits were determined as described above with 
the following modifications: BLG slide cell cultures inoculated with 
the 3374 strain of BHV-4 were treated with dilutions of serums from 
inoculated and control rabbits and then stained with fluorescein-con-
jugated goat anti-rabbit globulin (Cappel Lab., Downington, PA, USA). 
All of the serum samples from different times (pre and post-inoculation) 
corresponding to the same animal were titrated simultaneously, 
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RESULTS 
Clinical and Virological Observations 
'Clinical signs 
All rabbits of group 1, inoculated intravaginally, developed 
vaginitis, characterized by hyperemia and edema that extended to the 
vulva. By day 4 PI, a mucopurulent and often hemorrhagic secretion was 
evident along with abundant pseudomembranes and desquamated material. 
The vaginitis decreased in severity by day 6 PI, and by day 12 PI 
the vaginal mucosa appeared normal. A 24 hour febrile response was 
noticed at day 4 PI (rectal temperature: 40.9-41.2C) in five of the 
6 rabbits. The rabbits of group 3, infected in the right conjunctival 
sac, developed, at 48 hours PI, edema and hyperemia of the conjunctiva 
with injected scleral vessels in the eye infected. The left eye remained 
normal. The signs remitted by day 6 PI. No fever was detected in these 
animals. The vagina and eyes of the mock-infected control rabbits 
of group 6 remained normal. 
One .of the two rabbits of group 5 presented, at 48 hours PI, 
intense zones of hyperemia at the intradermal inoculation points. 
These areas became edematous nodules by day 3 PI and regressed by day 
6 PI. Viral isolation was not attempted from these lesions. All the 
rabbits of group 2, 4 and 6 remained normal. 
Virus isolation post-inoculation 
The viral replication after intravaginal and conjunctival 
inoculation is given in Fig. 1. 
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Figure 1. The mean and range of BHV-4 (strain 3374) titers in the 
right conjunctival sac and vagina of rabbits experimentally 
infected (N = 4 for conjunctival inoculation; N = 3 for 
vaginal inoculation). In both cases inoculum was 107,5 
TCID50/animal. 
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Virus could not be recovered from the uninoculated left conjunctiva. 
Virus was isolated only at day 1 PI from a nasal swab of one of two 
rabbits inoculated by intrapulmonary route. Virus was not recovered 
from the rabbits in the groups inoculated intravenously, intrapulmonary 
and intradermally. No virus was recovered from the mock-infected 
control rabbits. 
Dexamethasone treatment at 137 days PI caused neither recrudescence 
of disease nor reactivation of detectable virus in nasal, vaginal or 
ocular swabs, in any of the inoculated or control groups. 
Post mortem viral isolation 
A summary of virus isolation in the different groups of rabbits 
is given in Table 2. The virus was recovered from explants of spleen 
and cocultivations of splenic cells from all rabbits inoculated 
intravaginally (group 1) and intraconjunctivally (group 3) and from 
two of three rabbits inoculated intravenously (group 2). Virus was 
not isolated from explant cultures of spleen or splenic cell coculti-
vation of the remaining groups of rabbits and no virus was recovered 
from explant cultures of nervous tissues from rabbits of groups 1, 2 
and 6. 
The CPEs of BHV-4 were noticeable in BLG cells inoculated with 
supernatant of spleen explants after incubation of the explant ranging 
between 10 and 16 days. In addition, outgrowth of fibroblastic cells 
from the spleen explants became cytopathic between 12 and 20 days 
after explantation. Similar CPEs developed in the cocultures ELG/spleen 
Table 2. Viral isolations and serologic conversions after experimental infection of rabbits 
with BHV-4 (strain 3374) 
Group No. and 
Route of 
Inoculation 
1 (intravaginal) 
2 (intravenous) 
3 (conjunctiva!) 
Post-inoculation 
viral isolation 
6/6 
4 (intrapulmonary) 
0/3 
3/3 
1/2 
0/2 
0/4 
5 (intradermal) 
6 (control) 
* 
* IFA titers of the rabbit serums 
Preinoc, 20 Days PI 137 Days PI 
5 80 160 
5 80 320 
Neg 80 160 
Neg 80 113 
Neg 80 640 
5 Neg Neg 
Post-mortem viral isolation 
Spleent Nervous tissuet 
2/2(89 DPI) 
4/4(180 DPI) 
2/3(180 DPI) 
3/3(180 DPI) 
0/2(180 DPI) 
0/2(180 DPI) 
0/2(180 DPI) 
0/2(89 DPI) 
0/4(180 DPI) 
NT§ 
0/3(180 DPI) 
NT 
NT 
0/4(180 DPI) 
Data are expressed as the geometric means of the reciprocals of the IFA titer. 
t Explant cultures and cocultivation. 
+Explant cultures of paralumbar ganglia (goups 1 and 6) and trigeminal ganglia (groups 3 and 6). 
§ 
NT= not tested. 
"' N 
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cells after at least eight days of culture. All the isolates were 
confirmed as BHV-4 by IFA tests. No CPE could be detected in the 
BLG monolayers inoculated with cell-free homogenates of the splenic 
tissue. 
Serology 
The results of the serologic tests of all the rabbits are 
presented in Table 2. The preinoculation IFA titers were not higher 
than 1:5. At 20 days PI,all the rabbits inoculated with virus sero-
converted with titers ranging from 1:40 to 1:160. At 137 days PI,all 
these rabbits had increased antibody levels, with individual titers 
up to 1:1280. 
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DISCUSSION 
The results of these experiments indicate that the 3374 strain 
of BHV-4 is capable of establishing infection in rabbits when inoculated 
by intravaginal, conjunctival or intravenous routes. Clinical signs 
of acute disease were more restricted to the mucosal surface in which 
the virus was inoculated (groups 1 and 3), with practically no symptoms 
of generalized disease beyond a 24 hour fever in the animals inoculated 
intravaginally. During this acute period of disease, virus was recovered 
from the vagina and conjunctiva in titers that permitted comparison of 
the replication ~n both tissues. Virus also was isolated at day 1 PI 
from the nose of one rabbit of group 4 (intrapulmonary). This may 
represent clearance of the inoculated virus through the upper respiratory 
tract and not actual replication of virus in the respiratory tract. 
Serologic conversions were detected by IFA tests in all groups of animals 
inoculated with the virus. 
Previous works reported failure to establish an infection with 
BHV-4 in rabbits by several routes (Alexander et al., 1957; Luther et al., 
1971; Mohanty, 1973; Belak and Palfi, 1974) including intracerebral 
(Liebermann et al., 1967) and intradermal routes (Schiemann et al., 1971). 
Those authors could not detect antibodies against this virus in the rabbit 
sera when using the standard SN assay. Our results with IFA test confirm 
the previous report of Sass et al. (1974) about the higher sensitivity 
of this technique when compared with the SN assay in ability to detect 
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antibodies against BHV-4. The antibody titers we detected in rabbits 
were, in some cases, even higher than the ones we observed in experi-
mentally infected cattle (F. A. Osorio and D. E. Reed, Vet. Med. Res. 
Inst., Iowa State University, Ames, Iowa, submitted for publication, 1982) 
and they persisted at least for the duration of the experiment (6 months). 
Potgieter and Mare (1974) reported a rather transient antibody response, 
as measured by a 50% plaque reduction neutralization test with prolonged 
incubation of serum-virus mixtures, in rabbits hyperimmunized with the 
DN599 strain of BHV-4. 
The most significant information derived from this study is the 
demonstration that BHV-4 can persist in the rabbit in association with 
lymphoid organs, specifically the spleen. These results are similar 
to those found in experimentally infected cattle in which the virus 
could be detected in peripheral and visceral lymph nodes, spleen, tonsils 
and circulating leukocytes for extended periods of time (Osorio and 
Reed, 1982, submitted for publication). The virus was detected in the 
supernatant fluids of explant culture and in the coculture of splenic/BLG 
cells only after a prolonged incubation period which was never less 
than eight days. At the same time, lysates of the original splenic 
samples failed to yield infectious virus. This requirement for integrity 
of the cell and incubation to obtain expression of infectious virus is 
a characteristic we detected also in lymphoid tissues and leukocytes of 
persistently BHV-4 infected cattle (F. A. Osorio and D. E. Reed, Veteri-
nary Medical Research Institute, Iowa State University, Ames, Iowa, sub-
mitted for publication, 1982). This suggests that the virus may persist 
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in the splenic cell in a possible quiescent or latent state. Evidence 
for this feature has been found for other herpesviruses, especially 
in lymphoid tissues perisistently infected with Betaherpesviruses like 
murine cytomegalovirus (Henson et al., 1972; Ho, 1981) and (possibly) 
human cytomegalovirus (Lang and Noren, 1968; Rinaldo et al., 1977) 
as well as Gammaherpesviruses like Epstein-Barr virus (Ho, 1981) and 
malignant catarrhal fever virus (Patel and Edington, 1980). Alter-, 
natively, it also is possible that the virus was present in an actively 
replicating state, but in such a low titer that it was indetectable 
in the cell-free homogenates. 
All the isolates were confirmed as BHV-4 by IFA tests. The 
possibility that the isolates were laboratory contaminants is minimal 
considering that control ·rabbit spleens yielded no virus and the BLG 
cells carried along for cocultures and supernatant assays never developed 
CPEs. Furthermore, the isolations were made at a time when BHV-4 was 
not being passed in the laboratory. 
No persistent virus could be detected in groups 4 and 5 (intra-
pulmonar and intradermal inoculations), but a serologic response with 
high level of antibodies was detected in both cases. As the spleen was 
the only organ assayed for persistent virus in the rabbits of these 
two groups, the possibility that the virus did persist in other lymphoid 
organs (i.e., regional lymph nodes of the area of inoculation) cannot 
be discarded. 
Although for groups 1, 2 and 3 the virus was actually demonstrated 
to be persisting in the animals, the treatment with dexamethasone 
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failed to reactivate the virus. The chance of the splenic viral 
isolation being due to a reactivation caused by the dexamethasone treat-
ment is low since the virus was isolated in a similar manner from rabbits 
killed at day 90 PI, with no dexamethasone treatment, as well as from 
rabbits killed at day 180 PI which was 43 days after dexamethasone 
treatment. The use of corticosteroids to reactivate latent bovine 
herpesvirus-1 (BHV-1) was demonstrated to be very effective both in cattle 
(Davies and Carmichael, 1973) and in rabbits (Rock and Reed, 1982) 
where reactivation was obtained in essentially 100% of persistently 
infected animals. However, corticosteroids have poor efficacy of 
reactivation for latent Herpes simplex virus (HSV) in mice (Openshaw 
et al., 1979) and for latent bovine herpesvirus-2 (BHV-2) in cattle 
(Probert and Povey, 1975; Martin and Scott, 1979). Although the ultimate 
mechanism for costicosteroid viral reactivation has not been elucidated, 
this spectrum of responses could be due to a different susceptibility 
to the hormone of the diverse target cells .harboring herpepviruses, 
It is already known that BHV-1 (Lupton et al., 1980; Rock and 
Reed, 1980), BHV-2 (Castrucci et al., 1972) and bovine herpesvirus-3 
(BHV-3) (Patel and Edington, 1980) have the ability to establish experi-
mental infection in laboratory rabbits. This report provides evidence 
that BHV-4 also can be studied, in its acute and persistent infection, 
in a rabbit model. This will constitute a feasible tool to characterize 
the lymphoid association of BHV-4. 
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SUMMARY AND CONCLUSIONS 
This work involved investigation of the response of cattle 
and rabbits experimentally infected with a strain of BHV-4 isolated 
from a case of mammary pustular dermatitis. 
After infection of cattle by several routes, no clinical signs 
or lesions were evident, except for a dermal lesion corresponding 
with one intradermal inoculation point. Seroconversions were detected by 
the Indirect Fluorescent Antibody Test. Virus was recovered from the 
dermal lesion and was excreted in milk for 17 days. Virus also was 
recovered sporadically from esophagus-pharyngeal fluid. At different 
times of slaughtering (2 to 14 months postinoculation), virus was 
recovered from cocultures with bovine lung cells and/or explant cultures 
of lymph organs. A persistent viremia was detected and studied in 
2 of the cattle. The virus was recovered repeatedly throughout one 
year from peripheral blood leukocytes by cocultivation with bovine 
lung cells. The number of infectious leukocytes, as determined by 
Infectious Centre Assay, ranged from less than 1 to 6 infectious cells 
7 per 10 leukocytes. 
Inoculation of rabbits by various routes resulted in seroconver-
sions (Indirect Fluorescent Antibody Tests). After intravaginal and 
conjunctiva! inoculations, vulvovaginitis and conjunctivitis were 
evident and virus was shed. 
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The antibody titers persisted throughout the experiment. 
Treatment with dexamethasone, beyond the acute infection, did not 
produce recrudescence of disease or virus shedding. Rabbits were 
killed at various times from three to six months post-infection and 
the virus was recovered from explant cultures of spleen and by co-
cultivation of spleen cells with bovine lung cells. 
The following conclusions may be made: 
1. No evidence for a definite role of BHV-4 in clinical disease 
of cattle can be raised from this work. 
2. Bovine herpesvirus-4 is capable of establishing a persistent 
infection after experimental inoculation of cattle and rabbits. 
3. This persistent infection is associated with lymphoid tissue 
in both species. In cattle there is, concomitantly, a persistent 
viremia associated with the mononuclear cell fraction of the blood. 
4. Integrity of the lymphoid cell and long in vitro incubation 
appear to be requisites for recovery of infectious BHV-4. A quiescent 
or latent state of the virus within the lymphoid cell is possible. 
5. The association of BHV-4 with lymphoid organs and the MNC 
fraction of blood could explain the great diversity of tissues (and 
syndromes) from which BHV-4 has been recovered. 
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